This page has been archived.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
The Honourable Tony Clement, M.P.
Minister of Health
SECTION II – ANALYSIS OF PROGRAM ACTIVITIES BY STRATEGIC OUTCOME
SECTION III – SUPPLEMENTARY INFORMATION
SECTION IV – OTHER ITEMS OF INTEREST
It is with pleasure that I present the Public Health Agency of Canada’s 2008-2009 Report on Plans and Priorities, the Agency’s third such report on its corporate direction.
Canada is a great country with limitless potential, and Canadians have worked hard to create a solid foundation for our society and create a safe, healthy and prosperous nation for our children. Public health contributes to this foundation in many ways and is helping our Government deliver on its priorities for building a better Canada.
The Government of Canada is concerned with improving the quality and safety of our environment, not only the air that we breathe and the water we drink, but also ensuring that food for our families and the products we buy for our workplaces and homes are safe. The Agency supports the Government’s priorities through its expertise and networks on the surveillance of health outcomes. By highlighting links between exposure and illness, this work allows us to direct interventions where needed, and to in turn measure their effectiveness.
The Public Health Agency of Canada will also continue to lead the Government of Canada’s efforts, at home and internationally, on preparation and planning for a potential influenza pandemic and for any other emerging infectious disease that could threaten the health of our collective well-being. Through continued vigilance, the Agency works to ensure that early identification of and fast response to outbreaks will help reduce the impact of a pandemic on the health of Canadians.
An important step in reinforcing public health in Canada was the passing into law of the Public Health Agency of Canada Act in December 2006. The Act formally establishes the position of the Chief Public Health Officer of Canada and recognizes his unique dual role both as deputy head of the Agency and the Government of Canada’s lead health professional. The Agency also has recently released its five-year Strategic Plan that sets its direction and key priorities.
This is indeed a country of which we can be very proud. By working to improve and protect the health of Canadians, the Public Health Agency of Canada continues to play a key role in Canada’s enduring prosperity.
Tony Clement
Minister of Health
It has been over three years since the Public Health Agency of Canada was created to assist the federal government in protecting and promoting the health of the population. Emerging from the lessons of SARS we look back with some pride on the accomplishments of these first years as we
work to address the fundamental factors that impact on health.
Public Health is the first public good addressed by governments in health as we recognized the powerful relationship between economic, social and individual health and wellbeing.
Whether it is protecting from emerging or well known infections, preventing and managing chronic disease and injury, planning for and responding to emergencies, preparing for a pandemic, enhancing public health capacity, studying and addressing determinants of health, or conducting research and surveillance, public health inevitably touches all aspects of our lives. Sound public health is a solid foundation that supports all else in society.
Looking ahead, the current pace of change within our borders and around the world poses both challenges and opportunities for Canadians, from changing demographics, environmental impacts, rising obesity and chronic disease rates, to a growing awareness of the interconnectedness of the world and the accelerating pace of scientific and technological innovation. It is ironic testimony to our technical success that despite our advances we have neglected the basics of health and this generation of children may be the first to have a shorter life expectancy than their parents.
In facing these challenges and embracing these opportunities, the Public Health Agency’s vision remains constant and relevant: healthy Canadians and communities in a healthier world. The Agency will continue to develop, enhance and implement strategies and programs for the prevention of infectious disease, for the promotion of health, and for the prevention and control of chronic disease and injury. We will continue to strengthen Canada’s preparedness for emergencies and disasters, while increasing public health capacity and enhancing our national and international collaborations. The Agency remains the government-wide lead on efforts to study and address determinants of health.
Our new, first ever Strategic Plan articulates the Agency’s objectives and will guide us forward over the coming years.
New with this 2008-2009 Report on Plans and Priorities is a revised strategic outcome for the Agency: healthier Canadians, reduced health disparities and a stronger public health capacity. By specifically stating the goal of reducing health disparities, we emphasize one of our greatest public health challenges. Health inequalities in Canada will be the focus of the upcoming inaugural Chief Public Health Officer’s Report on the State of Public Health in Canada.
We look forward to the challenges ahead as we work together towards achieving “healthy Canadians and communities in a healthier world”.
Dr. David Butler-Jones
Chief Public Health Officer
I submit for tabling in Parliament, the 2008-2009 Report on Plans and Priorities (RPP) for the Public Health Agency of Canada.
This document has been prepared based on the reporting principles contained in the Guide for the Preparation of Part III of the 2008-2009 Estimates: Reports on Plans and Priorities and Departmental Performance Reports:
Dr. David Butler-Jones
Chief Public Health Officer
Health Portfolio Overview The Minister of Health is responsible for maintaining and improving the health of Canadians. This is supported by the Health Portfolio which comprises the Public Health Agency of Canada, Health Canada, the Canadian Institutes of Health Research, the Hazardous Materials Information Review Commission, the Patented Medicine Prices Review Board and Assisted Human Reproduction Canada. Each member of the Portfolio prepares its own Report on Plans and Priorities. The Health Portfolio consists of approximately 11 400 employees and an annual budget of over $4.5 billion. |
In September 2004, the Public Health Agency of Canada was created within the federal Health Portfolio to deliver on the Government of Canada’s commitment to help protect the health and safety of all Canadians and to increase its focus on public health. The Agency’s role is to help build an effective public health system in Canada – one that allows Canadians to achieve better health and well-being in their daily lives, while protecting them from threats to their health security.
Events like the emergence of severe acute respiratory syndrome (SARS) in 2003 demonstrated the need for Canada to have a national point of focus for public health issues. In response, the Public Health Agency of Canada was established on September 24, 2004, and Dr. David Butler-Jones was appointed as the country’s first Chief Public Health Officer (CPHO). The creation of the Agency marked the beginning of a new approach to federal leadership, and to collaboration with the provinces and territories in the Government’s efforts to renew the public health system in Canada.
On December 15, 2006, the Public Health Agency of Canada Act came into force. The Actcontinues the strong tradition of cooperation and collaboration that has been a part of Canada’s approach to public health for decades. The Act formally establishes the position of the Chief Public Health Officer and recognizes his unique dual role as deputy head of the Agency and as the Government of Canada’s lead public health professional.
The role of the Public Health Agency of Canada can be summed up as follows:
The Agency is mandated to work in collaboration with its partners to lead federal efforts and to mobilize pan-Canadian action in preventing disease and injury, and to promote and protect national and international public health by:
Type of Organization | Federal Agency funded by Parliament |
Mission | To promote and protect the health of Canadians through leadership, partnership, innovation and action in public health |
Vision | Healthy Canadians and communities in a healthier world |
Strategic Outcome | Healthier Canadians, reduced health disparities, and a stronger public health capacity |
Government of Canada Outcomes Directly Supported | Healthy Canadians Safe and secure communities |
Enabling legislation | Public Health Agency of Canada Act |
Acts and Regulations Administered | The Quarantine Act The Importation of Human Pathogen Regulations |
Program Activities | Health Promotion Chronic Disease Prevention and Control Infectious Disease Prevention and Control Emergency Preparedness and Response Strengthen Public Health Capacity |
Reporting to Parliament | The Agency reports to Parliament through the Minister of Health The CPHO is to submit a report to the Minister on the state of public health in Canada |
The following organization chart depicts how the Agency is structured within the Federal Health Portfolio.
To maintain the knowledge and skills needed to develop and deliver the public health advice and tools required by Canadians, the Agency calls upon the efforts of public health professionals, scientists, researchers, technicians, communicators, administrators, and policy analysts and planners. These employees work across Canada in a wide range of operational, scientific, technical and administrative positions.
The largest concentration of employees is in the National Capital Region. The head office in Winnipeg forms a second pillar of expertise. In times of a national health emergency, the Emergency Operations Centres (EOC), based both in Ottawa and Winnipeg, can be utilized to manage the crisis.
The Public Health Agency of Canada recognizes the need to have a strong presence throughout the country to connect with Provincial Territorial (P/T) governments, federal departments, academia, voluntary organizations and citizens. Outside of Winnipeg and the National Capital Region, the Agency’s Canada-wide infrastructure consists of sixteen locations in six Regions: British Columbia and Yukon, Alberta and Northwest Territories, Manitoba and Saskatchewan, Ontario and Nunavut, Quebec, and Atlantic. Some Agency programs are delivered to the Yukon, Nunavut and the Northwest Territories through Health Canada’s Northern Region office under an interdepartmental agreement.
The Agency operates specialized research laboratories in several locations across Canada. The Canadian Science Centre for Human and Animal Health in Winnipeg houses the Agency’s state-of-the-art National Microbiology Laboratory which is one of the world’s high containment research laboratories. The Agency’s Laboratory for Foodborne Zoonoses, which studies the risks to human health from diseases arising from the interface between animals, humans and the environment, is headquartered in Guelph, Ontario and maintains units in Saint Hyacinthe, Quebec and Lethbridge, Alberta.
The following map shows where the Agency’s staff, offices and laboratories are located (employee numbers are as of March 31, 2007):
A government-wide process to facilitate the full implementation of the Government of Canada’s Management, Resources and Results Structure Policy took place starting in 2006-2007 and continued in 2007-2008. As part of this process the Agency reviewed and restructured its Program Activity Architecture (PAA). Changes to the Strategic Outcome (SO) and Program Activity Architecture were approved by the Treasury Board on May 31, 2007, and come into effect on April 1, 2008.
2007-08 | 2008-09 | |
Strategic Outcome (SO) | Healthier Canadians and a stronger public health capacity | Healthier Canadians, reduced health disparities, and a stronger public health capacity |
Program Activities (PA) | Health Promotion | Health Promotion |
Disease Prevention and Control | Chronic Disease Prevention and Control Infectious Disease Prevention and Control |
|
Emergency Preparedness and Response | Emergency Preparedness and Response | |
Strengthen Public Health Capacity | Strengthen Public Health Capacity | |
Program Management and Support | Internal Services | |
Sub and Sub Sub Activities (SA and SSA) | 18 Sub Activities 0 Sub Sub Activities |
22 Sub Activities 6 Sub Sub Activities |
Notable changes include:
Main Estimates 2007-08 | ||||||
(millions) | (New) Health Promotion |
(New) Chronic Disease Prevention and Control |
(New) Infectious Disease Prevention and Control |
(New) Emergency Preparedness and Response |
(New) Strengthen Public Health Capacity |
Total |
(Old) Health Promotion |
186.4 | - | - | - | - | 186.4 |
(Old) Disease Prevention and Control |
- | 70.8 | 229.7 | - | - | 300.5 |
(Old) Emergency Preparedness and Response |
- | - | - | 115.8 | - | 115.8 |
(Old) Strengthen Public Health Capacity |
- | - | - | - | 55.6 | 55.6 |
Total | 186.4 | 70.8 | 229.7 | 115.8 | 55.6 | 658.3 |
Vote or Statutory Item |
Truncated Vote or Statutory Wording | 2008-09 Main Estimates |
2007-08 Main Estimates |
40* | Operating expenditures | 360.5 | 438.4 |
45* | Grants and contributions | 199.6 | 189.3 |
(S) | Contributions to employee benefit plans | 30.4 | 30.6 |
Total – Agency | 590.5 | 658.3 |
* In 2007-2008, Vote 40 and Vote 45 were numbered Vote 35 and Vote 40 respectively.
The decrease of $77.9 million in Vote 40 between the 2007-2008 and the 2008-2009 Main Estimates is mainly attributable to reduced requirements for preparedness for avian and pandemic influenza (-$82.8M) offset by funding received for the renewal of the Hepatitis C Prevention, Support and Research Program ($4.7M) and incremental funding in support of the Integrated Strategy on Healthy Living and Chronic Disease ($4.7M), and the Federal Initiative to address HIV/AIDS in Canada ($3.9M), the Expenditure Review Committee (ERC) reduction announced in Budget 2007 (-$2.9M) and the transfer to Western Economic Diversification Canada (WEDC) for the InterVac project in Saskatoon (-$3.0M).
The increase of $10.3 million in Vote 45 is mainly attributable to the renewal of the Hepatitis C Prevention, Support and Research Program ($4.9M) and incremental funding in support of the Integrated Strategy on Healthy Living and Chronic Disease ($3.8M), and the Federal Initiative to address HIV/AIDS in Canada ($3.6M).
Refer to the table on “Departmental Planned Spending and Full-Time Equivalents” for additional details regarding variances in planned spending.
($ millions) | Forecast Spending 2007-08 |
Planned Spending 2008-09 |
Planned Spending 2009-10 |
Planned Spending 2010-11 |
Health Promotion | 186.4 | 203.5 | 200.8 | 197.3 |
Chronic Disease Prevention and Control | 70.8 | 69.0 | 69.0 | 69.0 |
Infectious Disease Prevention and Control | 229.7 | 234.9 | 275.6 | 239.0 |
Emergency Preparedness and Response | 115.9 | 39.1 | 39.1 | 39.1 |
Strengthen Public Health Capacity | 55.6 | 44.1 | 44.8 | 45.2 |
Budgetary Main Estimates (gross) | 658.4 | 590.6 | 629.3 | 589.6 |
Less: Respendable revenue | (0.1) | (0.1) | (0.1) | (0.1) |
Total Main Estimates | 658.3 | 590.5 | 629.2 | 589.5 |
Adjustments | ||||
Supplementary Estimates (A): | ||||
Funding related to the renewal of the Hepatitis C Prevention, Support and Research Program | 9.7 | |||
Funding related to government advertising programs (horizontal item) | 2.2 | |||
Funding to the Canadian MedicAlert Foundation to assist the “No Child Without” Program | 2.0 | |||
Funding for risk assessments and targeted research in the area of Bovine Spongiform Encephalopathy (BSE) | 0.8 | |||
Funding to prepare for Canada’s participation in International Polar Year 2007-2008, an extensive international research program in the Arctic and Antarctic (horizontal item) | 0.4 | |||
Funding support of the Federal Accountability Act to evaluate all ongoing grant and contribution programs every five years (horizontal item) | 0.2 | |||
Spending authorities available within the Vote | (0.3) | |||
Transfer from Health – To adjust for the allocation of resources following the transfer of the control and supervision of the Population and Public Health Branch | 0.6 | |||
Transfer from National Defence – For public security initiatives (horizontal item) | 0.4 | |||
Transfer from Health – To support the Canadian Health Services Research Foundation’s Community Health Nursing Study | 0.1 | |||
Transfer from the Royal Canadian Mounted Police – For the initial planning related to policing and security for the 2010 Olympic and Paralympic Winter Games | 0.1 | |||
Transfer to Citizenship and Immigration – To support the Centres for Excellence in fostering and funding policy research related to immigration, integration and diversity (Metropolis Project) | (0.1) | |||
Transfer to Human Resources and Skills Development – To support the development of an Atlas on Country Resources for Intellectual Disabilities | (0.1) | |||
Transfer to the Canadian Institutes for Health Research – To fund health services and health population research relevant to the surveillance of diabetes | (0.2) | |||
Transfer to the Canadian Institutes for Health Research – To fund influenza research to strengthen Canada’s pandemic preparedness capacity | (0.4) | |||
Transfer to Western Economic Diversification – For the design and construction of the International Vaccine Centre’s (InterVac) Biosafety Level III Containment Facility in Saskatoon (horizontal item) | (3.0) | |||
Total, Supplementary Estimates (A) | 12.4 | |||
Supplementary Estimates (B): | ||||
Transfer to National Defence – To fund public security initiatives (horizontal item) | (0.3) | |||
Transfer to Canadian Institutes for Health Research – To fund Hepatitis C specific inter-disciplinary training programs | (0.3) | |||
Transfer to Health – To fund the Science Library Network | (0.3) | |||
Transfer to Canadian Institutes for Health Research – To fund Pandemic Influenza Research | (0.6) | |||
Total, Supplementary Estimates (B) | (1.5) | |||
Other adjustments: | ||||
Expected year end lapse for funding reprofiled to subsequent years | (40.1) | |||
Funds available internally from savings and other surpluses | (15.6) | |||
Transfer from Treasury Board Vote 22 for Operating budget carry forward | 14.8 | |||
Transfer from Treasury Board Vote 15 for collective bargaining agreement | 1.5 | |||
Employee Benefit Plan (EBP) | 1.0 | |||
Transfer from Treasury Board Vote 10 for allocation of ongoing incremental funding in support of the new requirements of the (2006) Policy on Internal Audit | 0.3 | |||
2010 Vancouver Winter Olympics | 0.1 | 3.4 | ||
Total, Other adjustments | (38.1) | 0.1 | 3.4 | |
Total Adjustments | (27.2) | 0.1 | 3.4 | 0.0 |
Total Planned Spending | 631.1 | 590.6 | 632.6 | 589.5 |
Plus: Cost of services received without charge (1) | 25.8 | 28.7 | 27.9 | 27.5 |
Total Departmental Spending | 656.9 | 619.3 | 660.5 | 617.0 |
Full-Time Equivalents | 2 376 | 2 452 | 2 463 | 2 449 |
The planned spending for 2007-2008 mainly represents funding received in Main Estimates and in Supplementary Estimates (A) and (B), adjusted to include employee benefit plans and anticipated surpluses.
Supplementary Estimates (B) are anticipated to be tabled in Parliament in February 2008.
The net decrease of $40.5 million between the total planned spending for 2007-2008 and 2008-2009 is mainly due to: reduced requirements for Preparedness for Avian and Pandemic Influenza (-$57.5M); funding received in 2007-2008 as a result of the 2006-2007 operating budget carry-forward exercise (-$14.8M) and for a one-time grant to the Canadian MedicAlert Foundation (-$2.0M) not required in 2008-2009; the sunsetting of funding in support of five-year projects under the Agriculture Policy Framework (-$1.4M) and three-year Genomics Research and Development projects (-$1.5M); reduction in employee benefit plans (-$2.9M); and Expenditure Review Committee (ERC) reduction announced in Budget 2007 (-$2.9M).
These reductions are offset by increases due to: forecasted internally generated savings ($15.6M), incremental funding for the Integrated Strategy on Healthy Living and Chronic Disease ($8.8M), and the Federal Initiative to address HIV/AIDS in Canada ($7.6M), the development and testing of a mock pandemic vaccine ($5.4M), the acquisition and retrofit of the Ward (Logan) Laboratory in Winnipeg ($3.5M), and the Canadian HIV Vaccine Initiative ($1.2M).
The increase of $42.0 million between the total planned spending from 2008-2009 and 2009-2010 is mainly due to funding received, which is to be transferred to provinces and territories under the Hepatitis C Health Care Services Program ($49.7M), for the Canadian HIV Vaccine Initiative ($8.5M), Preparedness for Avian and Pandemic Influenza ($4.3M), and for new funding related to the 2010 Vancouver Winter Olympics ($3.3M). These increases are offset by reduced funding for the maintenance of the National Antiviral Stockpile (-$12.6M), Preparedness for Avian and Pandemic Influenza ($-6.4M), the Ward (Logan) laboratory Project in Winnipeg (-$2.0M), and the sunset of the 2008 advertising plan (-$2.7M).
The decrease of $43.1 million between the total planned spending from 2009-2010 to 2010-2011 is mainly due to reduced funding for the Hepatitis C Health Care Services Program (‑$49.7M), and the First Nations and Inuit Health Programming (-$4.9M), reduced funding related to the 2010 Vancouver Winter Olympics (-$3.4M), offset by increases related to the Ward Laboratory Project in Winnipeg ($10.7M), the end of a three-year agreement for the InterVac project in Saskatoon ($3.0M), and incremental funding for Preparedness for Avian and Pandemic Influenza ($0.9M) and the Canadian HIV Vaccines Initiative ($0.3M).
2008-09 | 2009-10 | 2010-11 |
590.6 | 632.6 | 589.5 |
2008-09 | 2009-10 | 2010-11 |
2 452 | 2 463 | 2 449 |
Public health focuses on the entire population at both the individual and the community level. It encompasses a range of activities performed by all three levels of government in collaboration with a wide variety of stakeholders and communities across the country. Public health plays a key role in preparedness and planning for crises such as an influenza pandemic. It also includes day-to-day activities, such as immunization campaigns, nutrition counselling and restaurant inspections, which require policy, scientific and analytical support (e.g. laboratory research and analysis, epidemiology, surveillance, and knowledge translation).
Demographics
Changing demographics are an important factor in Canada. As noted in the 2006 Census, Canada has the highest rate of population growth in the G8, with the majority of this growth coming from immigration. As well, due to a combination of low birth rates and longer life spans, the age of Canada’s population continues to increase. In the next 10 years, Canadians over age 65 will
outnumber those under age 15. However, the exception to these demographics changes has been Canada’s Aboriginal peoples. While the majority of this population lives in urban settings, over a third still resides in isolated, poorly serviced communities with few economic opportunities. While the Aboriginal population is younger and faster growing than the rest of the Canadian
population, it also faces a number of specific health problems. All of these changes will have significant impacts in the incidence and distribution of many diseases and injuries, and will place increasing pressures on Canada’s health system.
Environment
Canadians are increasingly recognizing the linkages between health and the environment, not only in areas such as the effects of toxins and pollutants, but also the impacts of climate change and the trade-offs involved in sustainable development. Growing populations are placing an increased pressure on the environment globally while, in Canada, greater urbanization brings with it
increased demands for energy, land and other resources, as well as increased concentrations of toxins and pollutants.
Science and Technology
The rate of scientific discovery and technological innovation has increased dramatically in the past decade, but the impact on the health sector has been mixed. On one hand, advances in treatÂment and care offer new opportunities to address illness and improve health. On the other hand, these advances have increased the cost pressures on Canada’s already stressed health
system.
Globalization
Globalization has already had a profound impact on public health in Canada. The vast increase in the volume and speed of trade and travel has brought significant economic benefits to Canadians, while making available a greater range of consumer products and foods.
However, there are challenges that exist. Over the past 30 years, health in Canada and in other migrant-receiving nations has been increasingly influenced by human migration. Migration represents one way in which globalization has meant a greater risk from infectious disease, increasing both the likelihood of an outbreak and the speed of its transmission. Keeping pace with the demands of a global economy has meant greater time pressures for Canadian families, along with a proliferation of convenience foods and reduced time for physical activity. As well, globalization has had a major effect in the area of health security, as the free movement of people and ideas has also facilitated the export of instability and violence, bringing threats to the health and safety of Canadians. And while the risk of a health emergency remains low, the impact of an event, whether natural or man-made, could be catastrophic.
Infectious Disease
In addition, globalization has had profound and multiple implications for Canada. The increase in the speed and volume of global transportation places Canadians within 24 hours of almost any other place in the world. Recent events have highlighted the precarious nature of the current infectious disease landscape, increasing the need for national approaches to the global issue of
disease transmission and infection control, as evidenced by avian influenza outbreaks in various parts of the world, outbreaks of methicillin-resistant Staphylococcus aureus (MRSA) in neonatal intensive care units, C. difficile in hospitals, and the development of extensively drug resistant tuberculosis and other infectious diseases in the community setting.
Trends and Burden of Chronic Diseases in Canada
The increasing burden of chronic diseases is significant, both globally and in Canada. A number of specific trends are contributing to the incidence and prevalence of chronic diseases and the ability to address them through health promotion and chronic disease prevention efforts.
In 2004, 82% of all deaths in Canada were the result of chronic diseases, including cancer, cardiovascular disease and diabetes, with about 184 000 Canadians losing their lives to these diseases. At the same time, the rate of obesity, an important risk factor for diabetes, heart disease, stroke and some cancers, is growing worldwide, leading to significant increases in heart disease and other major causes of death. With respect to mental illness, 11% of (or 2.7 million) Canadians have mood disorder, anxiety disorder or substance dependence. According to year 2000 data, the estimated economic burden of the major chronic diseases in Canada (diabetes, cancer, cardiovascular disease, musculoskeletal, neurodegenerative and respiratory diseases) was $108 billion.
Among the trends contributing to the overall growing social and economic burden of chronic disease are an ageing Canadian population, escalating rates of overweight and obesity among children, youth and adults, and increasing health inequalities, particularly among certain vulnerable or at-risk populations.
Determinants of Health and Health Inequalities
Decades of research demonstrates that for population health gains to be achieved, interventions must address the underlying factors and conditions that lead to poor health and health inequalities. At every stage of life, health is determined by complex interactions between the social, physical and economic environments in which people live. Differences in how people experience
these determinants of health lead to health inequalities.
Canadians have been among the healthiest people in the world, but if inequalities in health outcomes are not addressed, this status will be difficult to maintain in the future. Major health-related inequalities in Canada are related to factors such as socio-economic status, Aboriginal heritage, gender, immigrant status and geographic location. To effectively address the root causes of health inequalities and the health issues to which they contribute, public health has a critical leadership role to play in coordinating the efforts of and collaborating with a range of other relevant sectors.
Public Health Capacity
One of the most significant challenges facing all governments is the traditionally weak and limited public health capacity in Canada. Gaps in this capacity have been identified by governments, and were highlighted by the events of the SARS outbreak of 2003. Although improvements have been made since that time, there remains a lack of qualified public health professionals across
Canada, gaps in systems for communications and information-sharing, and uneven resources and capacity across jurisdictions.
These are only a few of the most significant issues that the Agency’s activities must be able to respond to while continuing to fulfill its mandate to promote and protect public health.
The Public Health Agency of Canada will continue to meet its responsibilities in providing federal leadership in public health, building domestic and international partnerships to improve health outcomes and building capacity and expertise to meet new challenges that threaten the health of Canadians. Recognizing that the public health system is a jigsaw puzzle where all of the pieces need to fit together, the Agency’s focus for the next three years will be on developing and delivering integrated approaches that cross sectors and jurisdictions. This will help to promote health, to prevent and control infectious and chronic diseases and injuries, to prepare for and respond to public health emergencies, and to develop public health capacity in a manner consistent with a shared understanding of the determinants of health and of the common factors that maintain health or lead to disease and injury.
In summary, these initiatives will further the ability of the Government of Canada to address Canadians’ concerns that their health system be adaptable, responsive to emerging threats, and able to meet their needs. The Public Health Agency of Canada will work toward meeting the demand for an integrated health system that places an emphasis on promotion and prevention over the full range of the determinants of health, while providing treatment and care. To this end, the Agency will work strategically with key partners – such as provinces, territories, international institutions and stakeholders within and beyond the health sector – whose cooperation is fundamental to the achievement of its mandate.
Efforts are being made to improve the health of all Canadians, in order to reduce or manage risk factors, such as physical inactivity, unhealthy eating, and unhealthy weights, that can often prevent or delay the onset of chronic diseases, such as cancer, cardiovascular disease and diabetes, and so reduce the number of Canadians waiting for treatment for these diseases. However, a balanced approach must be taken from health promotion, through chronic disease prevention, to early detection and effective chronic disease management, if the overall burden on the health system is to be reduced. Within this balanced approach, significant effort needs to be directed towards addressing the underlying societal factors that contribute to health and impede progress on the major preventable chronic diseases and conditions, for example, obesity. Intervention at multiple entry points and levels is needed to address the complexity and underlying determinants of these public health issues, to slow and reverse chronic disease trends in Canada.
2008-09 | 2009-10 | 2010-11 |
203.5 | 200.8 | 197.3 |
2008-09 | 2009-10 | 2010-11 |
543 | 542 | 530 |
The decrease of $2.7 million between 2008-2009 and 2009-2010 reflects the end of the 2008 advertising plan.
The decrease of $3.4 million between 2009-2010 and 2010-2011 is mainly due to the sunsetting of five-year funding received for the First Nations and Inuit Health Programming (-$4.9M), offset by the end of the agreement with Western Economic Diversification Canada for the InterVac project ($1.2M);
Health promotion is the process of enabling people to increase control over their health and its determinants, thereby improving their health. In its health promotion activities, the Agency takes a population health approach, recognizing that health promotion must address broader determinants if it is to have an impact on improving Canadians’ health outcomes. The Agency’s health promotion activities focus on: the expansion of knowledge and evidence, including surveillance activities; policy leadership; the provision of relevant public information; increasing national and international community capacity; and fostering collaboration among sectors and across jurisdictions. The Population Health Promotion Expert Group, which reports to the F/P/T Public Health Network Council, is an important collaborative mechanism that will continue to be utilized to deliver on the Agency’s health promotion priorities.
The Agency’s healthy living activities are focused on promoting physical activity, healthy eating and healthy weights. Physical inactivity, poor nutrition and their adverse health effects represent a growing global health crisis and an increasing burden on public health systems in Canada and worldwide. Due to its prevalence, physical inactivity is the largest contributor to ill health and chronic disease in Canada.
The framework for the Agency’s work on healthy living is the Healthy Living and Chronic Disease initiative, which among other objectives, provides the federal contribution to the delivery of the Federal, Provincial, Territorial (F/P/T) Integrated Pan-Canadian Healthy Living Strategy. The vision of the federal Healthy Living and Chronic Disease initiative is to promote a comprehensive approach across a range of public health activities including the promotion of health, and the prevention, management and control of chronic health problems, with a view to building a healthier nation, decreasing health disparities, and contributing to the sustainability of the health system in Canada.
The Agency’s efforts aimed at supporting improved health outcomes for children and youth in Canada will continue to focus on the following key areas:
Preventing injuries contributes to a healthier society, reduces health care utilization and therefore contributes to shorter wait times. The Agency will continue to work with injury and violence prevention stakeholders on a range of activities to address this important public health issue as well as continue to conduct surveillance of unintentional child injury and child abuse and neglect. The Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP), which the Agency carries out in partnership with 14 hospitals across the country, will maintain data collection and dissemination of information to support child injury prevention and safety promotion. The Agency will enter into the pre-data collection phase for the third cycle of the Canadian Incidence Study of Reported Child Abuse and Neglect (CIS-2008). The CIS provides estimates of the national incidence of child maltreatment investigated by child welfare services and information about the circumstances of the affected children and their families, using the population health approach. Other surveillance efforts include the continuation of an interactive Web site that provides current Canadian injury data, entitled Injury Surveillance On-Line (http://dsol-smed.hc-sc.gc.ca/dsol-smed/is-sb/index_e.html).
In addition, the Agency will continue to lead and coordinate the Family Violence Initiative (FVI), a partnership of 15 federal departments, agencies and crown corporations and to operate the National Clearinghouse on Family Violence on behalf of the Initiative (www.phac-aspc.gc.ca). Through the National Clearinghouse and other mechanisms, the FVI develops knowledge and promotes public awareness of the risk factors of family violence, fosters collaboration and provides opportunities for the joint action to address issues, such as child maltreatment, intimate partner violence and the abuse of older adults. Over the three-year planning period, the Agency will continue to play a central role in knowledge and policy development, research and information dissemination in this area.
The aging of the Canadian population has serious public health implications. Evidence shows that health promotion and disease prevention strategies can help those who are aging well, those with chronic conditions and those who are at risk for serious problems even very late in life. The Agency is the federal government’s centre of expertise and focal point on seniors’ health, and provides leadership through policy development, knowledge development and exchange, and community-based interventions and partnerships. Its efforts are focused on four main areas: emergency preparedness, active aging, injury prevention, and mental health. During the reporting period, the Agency will also continue to identify key policy options to address gaps and encourage use of better practices and opportunities for further collaborative action across jurisdictions.
Mental illness is considered one of the most significant public health challenges of the 21st century. According to the WHO, depression will rank second only to heart disease as the leading cause of disability worldwide by 2020. One in five Canadians will experience a mental illness in their lifetime, while nearly one million live with a severe or persistent mental illness. During the planning period, the Agency will continue to advance mental health promotion, mental illness prevention and related issues including supporting the work of the Mental Health Commission, collaborating across governments and examining the workplace as a key venue for addressing mental health and mental illness.
The Agency will continue to lead national efforts to advance action on the determinants of health. Taking leadership means strengthening the Agency’s work in the area of reducing health inequalities, enhancing partnerships within and across other government departments, jurisdictions, and sectors (including non-government organizations and the private sector) to address the underlying determinants of health. Such action is critical to achieving health gains and reducing the social and economic impacts of health inequalities. Through the development of new knowledge, strategic partnerships and intersectoral policy initiatives, the Agency is contributing to a better understanding of the ways in which the determinants of health can be more effectively addressed within and outside of the health sector.
The Agency has made an effective contribution to the WHO Commission on Social Determinants of Health (CSDH). Canada’s support for knowledge networks on early child development, the impact of globalization on health and health systems has successfully advanced global knowledge in these areas. In addition, the new knowledge and evidence produced by the Commission overall will be instrumental in advancing policy and action to address the Social Determinants of Health in Canada. A key component of the Agency’s work with the WHO CSDH is providing leadership and support to the Canadian Reference Group on Social Determinants of Health (CRG), with its mandate to provide advice, facilitate initiatives that fill gaps, and engage non-government stakeholders.
Obesity has emerged as a significant public health challenge with major health, economic and social implications. At present, approximately 25 percent of all children and youth and more than half of all adults in Canada are classified as overweight or obese. Moreover, overweight and obesity incidence and prevalence rates are projected to escalate in coming years. To date, federal health promotion and disease prevention approaches with obesity-related elements have not been effective in counteracting the complex societal conditions that have contributed to escalating overweight and obesity trends.
A new comprehensive approach will comprise multi-sectoral policies and interventions that address the underlying societal causes of overweight and obesity, as well as approaches to enhance treatment and support options for Canadians who are overweight and obese. In addition, a framework will be developed to support a coherent and complementary approach with existing obesity-related health promotion and chronic disease prevention strategies and initiatives.
Stakeholder engagement strategies will reach beyond the federal family to establish partnerships with, and facilitate action by, other levels of government, the private-sector, and international and non-governmental organizations.
2008-09 | 2009-10 | 2010-11 |
69.0 | 69.0 | 69.0 |
2008-09 | 2009-10 | 2010-11 |
288 | 288 | 288 |
Working in cooperation with regional, P/T, national and international governments and stakeholders (including NGOs), the Agency provides national population health assessment and surveillance in relation to chronic diseases. It also provides leadership and expertise in the development and implementation of pan-Canadian chronic disease prevention and control strategies. Chronic diseases are among the most common, preventable and costly health problems facing Canadians.
The Agency provides leadership, expertise and support to develop and implement pan-Canadian chronic disease prevention and control initiatives. By creating public health platforms that engage and support provinces, territories and stakeholders, the Agency promotes health, contributes to chronic disease prevention and risk reduction, and facilitates efforts to improve early detection and management of chronic disease.
Chronic disease and risk factor surveillance support the Minister’s responsibility to be vigilant of the health of Canadians and contribute to Canada’s capacity to measure progress on chronic disease prevention and control. Knowledge Development, Exchange and Transfer (KDET) support public health practitioners and decision makers by making known “what works best” so that it can be put into practice. Through international collaboration, effective public health solutions are understood and shared globally.
Surveillance information on chronic diseases, their risk factors and determinants, and their impact and outcomes, is needed to plan, implement, and assess chronic disease prevention and control programs, policies and services. Surveillance is the tracking and forecasting of health events through the ongoing collection, integration, analysis, and interpretation of data, and the dissemination of information to public health planners and policy makers resulting in public health action.
The Agency is working with F/P/T partners to enhance chronic disease surveillance, which will increase access to and use of surveillance information, expand data sources, and improve the planning, coordination and evaluation of surveillance activities. This approach supports evidence-based decision-making on health promotion and chronic disease prevention and control.
The Agency continues to develop the Observatory of Best Practices to identify best practices for population-based chronic disease interventions and disseminate this information. The Canadian Best Practices Portal, launched in November 2006, offers an online database of evidence-based best practices for health promotion and chronic disease prevention (http://cbpp-pcpe.phac-aspc.gc.ca/). The Agency continues to support the revitalization of the Canadian Task Force on Preventive Health Care (http://www.ctfphc.org) and to combine this renewal with broader efforts for knowledge development, exchange and transfer.
Knowledge development and exchange support the application in practice of effective chronic disease prevention approaches. The Agency is facilitating provinces and territories in their efforts to enhance this capacity in their chronic disease programs by supporting and assessing the demonstration site components of P/T Chronic disease prevention initiatives.
By applying standard scientific assessment techniques to each provincial or territorial project, program comparisons will advance understanding of the factors that result in greatest impact.
Through its WHO Collaborating Centre on Chronic, Non-communicable Disease (CNCD) Policy, the Agency contributes to the strengthening of the global response to chronic diseases and to the development and implementation of chronic disease prevention policy in Canada, the Americas and Europe. The WHO Collaborating Centre maintains an ongoing commitment of technical support for CNCD policy analysis to the WHO Country-wide Integrated Non-Communicable Disease Intervention (CINDI) program in Canada and Europe, and to the PAHO-CARMEN program, its equivalent in the Americas. The Collaborating Centre is co-sponsoring, with the Pan-American Health Organization (PAHO), the development of a Chronic, Non-Communicable Disease Observatory of Policy Development and Implementation Processes in Latin America.
Through the Healthy Living and Chronic Disease initiative, the Canadian Diabetes Strategy focuses on preventing diabetes and its implications through action on risk factors, early detection and management of diabetes.
Approximately 2 million Canadians of all ages live with either type 1 or 2 diabetes and many more adults are unaware that they have the disease. As the Canadian population ages and rates of obesity rise, the prevalence of type 2 diabetes is expected to continue to increase. The evidence shows that a substantial proportion of cases of type 2 diabetes, the predominant type, can be prevented or delayed through targeted and sustained efforts to improve lifestyles among high-risk populations. Obesity, poor diet and physical inactivity are significant risks for diabetes.
The Canadian Diabetes Strategy targets populations at higher risk of developing diabetes, especially those who are overweight, obese or have pre-diabetes. Other target populations include individuals who are over age 40, have high blood pressure and high cholesterol or other fats in the blood (e.g. triglycerides), have a family history of diabetes, or are members of high-risk ethnic populations.
One of the priorities for this period will be the Diabetes Policy Review announced in October 2006. The review of the Canadian Diabetes Strategy will help ensure that government policies and programs meet the needs of Canadians living with diabetes and those at risk of developing the disease.
The Agency’s cancer program includes the Healthy Living and Chronic Disease Initiative cancer component, the Canadian Breast Cancer Initiative, and the Canadian Strategy for Cancer Control. The Healthy Living and Chronic Disease initiative supports cancer surveillance, screening, risk analysis and community-based programming. The Canadian Breast Cancer Initiative supports breast cancer research, prevention, early detection and quality screening, surveillance and monitoring, treatment and care enhancements, and community capacity building.
In November 2006, the Government announced the creation of the Canadian Partnership Against Cancer (CPAC), an independent, not-for-profit corporation which brings together cancer survivors, experts and government representatives from across the country. Of the $260 million/five years budgeted for the Canadian Strategy for Cancer Control, the Agency will receive $1 million per year over five years. This will be used to support links between the CPAC’s knowledge translation activities and other cancer portfolio members, and to promote international activities and federal leadership on cancer.
It is estimated that more than 159 900 Canadians were diagnosed with cancer and 72 700 died from the disease in 20071. The increased number of new cases of cancer is primarily due to a growing and aging population. By 2020, population aging is expected to contribute to more than double the number of new cases of cancer in Canada. Mortality rates have declined for all cancers combined and for most types of cancer in both sexes since 1994. Exceptions are lung cancer in females and liver cancer in males.
In Canada, 1 in 9 women will develop breast cancer in her lifetime, and 1 in 27 will die from it.2 Breast cancer is the most frequently diagnosed type of cancer in Canadian women. By monitoring and evaluating organized breast cancer screening programs in the country, it is possible to promote high-quality screening, leading to reductions in breast cancer mortality and morbidity.
Close to 1 300 children and adolescents are diagnosed with cancer every year in Canada, of which 210 die from their disease.3 Prevention activities targeting high-risk individuals can significantly reduce the number of new cases of cancer, although risk factors, detection, and management issues specific to this disease remain.
1 Canadian Cancer Society and National Cancer Institute of Canada. Canadian Cancer Statistics 2007, p. 12.
2 Canadian Cancer Society and National Cancer Institute of Canada. Canadian Cancer Statistics 2007, p. 70.
3 Canadian Cancer Society and National Cancer Institute of Canada. Canadian Cancer Statistics 2007, p. 67
Through the Healthy Living and Chronic Disease initiatives, Cardiovascular disease (CVD) investments focus on a pan-Canadian cardiovascular policy framework in collaboration with stakeholders.
Cardiovascular disease is the leading cause of death in Canada. Heart disease and stroke also put the greatest economic burden on our health care system, accounting for over $20 billion annually in direct and indirect costs ($12 billion among men and $8.2 billion among women). Cardiovascular disease is linked to several risk factors including hypertension, diabetes, obesity and tobacco use. Out of 10 Canadians, 8 have at least one risk factor for cardiovascular disease, and 1 in 10 has three risk factors or more.
In October 2006, the Health Minister announced the creation of a Canadian Heart Health Strategy and Action Plan (CHHS-AP) to develop a comprehensive plan for the prevention and treatment of heart disease.
In 2008-2009, a priority will be to continue supporting the development of the Pan-Canadian cardiovascular disease policy framework in collaboration with stakeholders. The policy framework and action plan will inform both integrated and cardiovascular disease-specific future federal investments. Until collaborative priority setting is undertaken through the CHHS-AP development process, federal cardiovascular investments will focus on hypertension, a recognized cardiovascular risk factor and the development of cardiovascular disease surveillance. Subsequently, implementation in other areas, informed by the collaborative action plan, will begin.
The Agency monitors and responds to emerging priorities related to public health and chronic diseases, such as obesity and respiratory diseases. In 2008-2009, the Agency’s focus for emerging priorities will be:
Over 3 million Canadians are affected by five serious respiratory diseases - asthma, Chronic Obstructive Pulmonary Disease (COPD), lung cancer, tuberculosis and cystic fibrosis. Respiratory diseases, including lung cancer, are the third leading cause of death, responsible for 17.6% of deaths among men and 15.3% of deaths in women.
In Canada, it is now estimated that one in five people has a breathing problem. In particular, we are seeing increased prevalence of asthma – 2.7 million Canadians now have this disease, which affects over 15% of children and over 8% of adults.
The Agency is collaborating with the Canadian Lung Association and stakeholders from across Canada to develop a coordinated action plan – the National Lung Health Framework – to help prevent and manage respiratory diseases.
From 2000 to 2005, the number of Canadians diagnosed with arthritis increased from 3.9 to 4.4 million; 60% of cases were women and three out of five Canadians with arthritis were under 65 years of age. Arthritis ranks second and third among the most commonly reported chronic conditions in women and men, respectively. In 1998, musculoskeletal conditions, including arthritis, were the category of diseases with the second highest estimated economic burden in Canada at $16.4 billion.
The overarching framework being built around the federal plan of action on overweight and obesity, referred to in the Health Promotion Program Activity, will support a coherent and complementary approach to addressing the issue by ensuring the links between comprehensive policy development, new approaches, and existing obesity-related health promotion and chronic disease prevention actions, strategies and initiatives. Intervention at multiple entry points and levels is needed to address the complexity of the issue and continue action towards slowing and reversing overweight and obesity trends in Canada.
The Agency’s ongoing obesity surveillance and knowledge, development, exchange and transfer activities aim to support the reduction of the preventable chronic disease burden in Canada by advancing knowledge of the underlying societal determinants of obesity and informing the understanding of promising interventions.
The impact of some common chronic diseases is growing and putting an increasing strain on the health care system. In order to better understand and plan for future disease prevention and management, the Agency will explore approaches to gaps in the surveillance of chronic diseases such as autism. This will include collaboration with Statistics Canada to develop a supplement to the Canadian Community Health Survey to survey chronic respiratory disease, arthritis and musculoskeletal disease, mental illness and neurological conditions.
2008-09 | 2009-10 | 2010-11 |
234.9 | 275.6 | 239.0 |
2008-09 | 2009-10 | 2010-11 |
1 101 | 1 109 | 1 107 |
The increase of $40.7 million between 2008-2009 and 2009-2010 is mainly due to funding received for the Hepatitis C Health Care Services Program and the Canadian HIV Vaccine Initiative; offset by incremental funding for Preparedness for Avian and Pandemic Influenza.
The decrease of $36.6 million between 2009-2010 and 2010-2011 is mainly due to the sunsetting of funding received for Hepatitis C Health Care Services Program offset by incremental funding for the Ward (Logan) Laboratory project in Winnipeg.
The program promotes improved health for Canadians in the area of infectious diseases through public health actions including surveillance and epidemiology, risk management, public health policy development, and prevention and care programs. This program is necessary as infectious diseases require national attention and national efforts given their current and potential impact on the health of Canadians and the Canadian health care system, and also because new, existing, or re-emerging infectious diseases can pose a serious threat to the health and socio-economic well-being of Canadians.
The program promotes prevention and access to diagnosis, care, treatment and support for those populations most affected by the HIV/AIDS epidemic in Canada - people living with HIV/AIDS, gay men, Aboriginal people, people who use injection drugs, inmates, youth, women, and people from countries where HIV is endemic. It also supports multi-sectoral partnerships to address the determinants of health. The program includes surveillance, knowledge development, partnership and community programming, laboratory sciences, health promotion, capacity building, policy development, leadership and coordination, social marketing and HIV vaccine development.
The number of Canadians living with HIV was estimated to be 58 000 in 2005, an increase of 16% from 2002 estimates. About 27% of these individuals were unaware of their infection at the end of 2005. This means that at the end of 2005 there were an estimated 15 800 infected individuals who had not had the opportunity to take advantage of available treatment strategies or appropriate counseling to prevent the further spread of HIV.
The Agency has the lead for federal action on the prevention of HIV/AIDS in Canada with key partners as outlined in “Leading Together: Canada Takes Action on HIV/AIDS (2005-2010)”. The Agency is responsible for overall coordination of the Federal Initiative to Address HIV/AIDS in Canada, a framework for renewing and strengthening the federal role in the Canadian response to HIV/AIDS, and for the Canadian HIV Vaccine Initiative (CHVI).
The Federal Initiative is a partnership among the Public Health Agency of Canada, Health Canada, the CIHR and Correctional Service Canada. Through the Federal Initiative, the Agency supports activities that will prevent new HIV infections, slow the progression of HIV/AIDS, improve the quality of life for affected people, reduce the social and economic impact of the disease, and contribute to the global efforts against the epidemic.
The Canadian HIV Vaccine Initiative is a collaborative undertaking between the Government of Canada and the Bill and Melinda Gates Foundation to contribute to the global effort to develop a safe, effective, affordable and globally accessible HIV vaccine. Participating federal departments and agencies include the Public Health Agency of Canada, Industry Canada, Health Canada, the Canadian Institutes of Health Research, and the Canadian International Development Agency. In support of the CHVI, the Agency supports activities that increase pilot scale manufacturing capacity for HIV vaccine clinical trial lots, strengthens policy approaches for HIV vaccines and promotes the community and social aspects of HIV vaccine research and delivery, and ensures horizontal collaboration within the CHVI and with domestic and international stakeholders.
Over the next three years, the Agency will work towards delivering on key policy and program initiatives to further the new Canadian HIV/AIDS Vaccine Initiative by:
As well, the Agency will provide secretariat support services to ensure an integrated delivery of CHVI policies, programs and initiatives with domestic and international linkages, including:
Through the ongoing Federal Initiative to Address HIV/AIDS in Canada, the Agency will:
The program provides avian and pandemic influenza preparedness and response measures to help ensure the health and safety of Canadians, to assist in mitigating potential social and economic disruption, and to support large-scale improvements to the Canadian public health system. Activities include the maintenance of the Canadian Pandemic Influenza Plan for the Health Sector (CPIP); developing and maintaining domestic pandemic vaccine production capacity; production and testing of a prototype pandemic vaccine; establishing an adequate reserve of antiviral medication; monitoring, detecting, and reporting unusual respiratory illnesses; strengthening collaboration with P/T and international governments, pandemic influenza research activities; providing technical support and expertise on human health issues related to avian influenza; and partnership with national and international organizations to strengthen surveillance, laboratory capacity, emergency preparedness and communications.
To ensure a timely, efficient and appropriate response by the Government of Canada during a pandemic, the following measures are part of a $1 billion initiative to address significant pandemic issues. These issues include:
Through the Canadian Public Health Laboratory Network (CPHLN):
Through work coordinated at the National Microbiology Laboratory (NML) and together with other federal and provincial public health laboratories, the Agency is demonstrating its continuing commitment to its pandemic preparedness by:
The NML, through the CPHLN, is strengthening nation-wide public health laboratory capacity during a pandemic via the creation of the Pandemic Influenza Laboratory Preparedness Network (PILPN) which will:
With respect to the diagnosis and pathogenesis of respiratory viruses, the NML will:
The Emergency preparedness and response program aims at developing exercises to evaluate the capacity to respond to emergency situations. It provides appropriate ongoing training to public health emergency response personnel and procures supplies to adequately respond to emergencies including potential influenza pandemic.
The program seeks to reduce or eliminate vaccine-preventable diseases excluding pandemic influenza, reduce the negative impact of emerging and re-emerging respiratory infectious diseases and adverse events following immunization, and maintain public and professional confidence in immunization programs. This includes nationally coordinated surveillance, epidemiology, and research for vaccine-preventable and respiratory infectious diseases, implementation of the National Immunization Strategy (NIS), including immunization registry development, national goals and objectives, vaccine supply, vaccine safety, and public and professional education, enhancing preparedness, national and international collaboration, and developing guidelines and protocols.
Continue to strengthen Canada’s ability to manage and respond to emerging and re-emerging infectious diseases and respiratory infections through the prevention, reduction or elimination of vaccine-preventable and infectious respiratory diseases. In addition, the Agency will continue to reduce the negative impact of these respiratory infections, and maintain public and professional confidence in immunization programs in Canada.
The program includes prevention, control, support and research activities aimed at addressing communicable diseases that can be acquired within the community or within health care settings, and any associated health risks and determinants. A specific component addresses communicable diseases at large, from an international and migration health perspective, as a cross-cutting issue for the Agency. Diseases include sexually transmitted diseases (STIs) or blood-borne infections (e.g. Hepatitis B and C, excluding HIV), tuberculosis, Creutzfeldt-Jakob, C. difficile, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and issues such as anti-microbial resistance, transplantation/transfusion transmitted injuries/ infections, and blood safety.
To further assist the Agency in the area of communicable diseases, the NML will:
In addition the Agency will:
The Agency will work towards developing initiatives on infection control to improve prevention, early detection, containment and response capacity across Canada. These initiatives could address diseases such as XDR TB and MRSA which has moved beyond the limits of the hospital setting and has become established in localized vulnerable populations and communities. For example, CA-MRSA outbreaks are occurring in various localities across Canada with the most recent being in Nunavut. As such, the Agency is exploring the establishment of a survey to identify the prevalence of CA-MRSA in Canadian communities.
With federal funding provided to the P/Ts for the HPV vaccine and with the implementation of publicly funded vaccine programs within the P/Ts there has been a need to undertake surveillance and education activities to support the P/Ts and monitor the virus. The Agency has initiated surveillance and education activities and will need to continue and expand current efforts in anticipation of the approval of other HPV vaccines, new formulations and expanded indications, such as the immunization of males.
The program includes surveillance, research, risk analysis and response to address the incidence and mitigate the burden of, foodborne, waterborne, and zoonotic illness in Canada; investigation and coordination of outbreak response, population and targeted research; and establishment of national surveillance capacity through consultation and coordination. The program strengthens public health capacity through technology and training, investigation of burden of disease and risk factors for infections, and development of national guidelines relating to risk reduction and prevention. Diseases being addressed include E. coli, Salmonella, Campylobacter, Hepatitis A, Norovirus, West Nile Virus, Lyme disease, rabies, and other emerging and re-emerging risks resulting from changes to behaviour, the climate, the environment and other factors.
The program generates and translates knowledge into effective national public health policy and actions. This includes the development of unique capabilities as a national resource, with a focus on infectious disease prevention and control, the application of biotechnologies and genomics to population health, and mitigation of human illnesses arising from the interface between humans, animals, and the environment. Projects undertaken by the National Microbiology Laboratory (NML) and the Laboratory for Foodborne Zoonoses (LFZ) strengthen public health capacity through research, reference services, development of innovations such as the Canadian Network for Public Health Intelligence (CNPHI) and the Global Public Health Intelligence Network (GPHIN), emergency research capacity, health risk modeling, and management of intellectual assets to improve public health and better respond to emerging health risks in Canada and internationally.
As part of the continued development of CNPHI web-based applications the Agency will:
2008-09 | 2009-10 | 2010-11 |
39.1 | 42.4 | 39.0 |
2008-09 | 2009-10 | 2010-11 |
271 | 271 | 271 |
* Additional funding of $0.1M for 2008-2009 and $3.4M for 2009-2010 are planned for increased security measures at the 2010 Vancouver Winter Olympics.
A series of domestic and international public health safety and security threats associated with natural and human-caused disasters confront the health safety and security of Canadians. These threats have been particularly evident by the emergence of Severe Acute Respiratory Syndrome (SARS), Avian Influenza, the Asian tsunami and Hurricane Katrina. These events and numerous other natural and man-made disasters are occurring in a global public health environment shaped by complex social, economic and environmental factors.
On the domestic front, demographic challenges such as aging and vulnerable populations as well as health and income disparities among population groups pose serious ongoing challenges in the development of uniform and robust emergency preparedness and response capacities across a vast and sparsely populated country.
This complex interplay of domestic and international health factors requires a comprehensive and highly collaborative approach to disaster preparedness, response and mitigation on the part of the Public Health Agency of Canada. With this in mind, the Agency takes a proactive “all hazards” approach to emergency management, working with emergency preparedness and response (EPR) partners and stakeholders across Canada to prepare for and respond to natural and human-caused health emergencies at anytime, anywhere across the country.
The Program manages and supports the development of health-related emergency response plans, including the Canadian Pandemic Influenza Plan (CPIP). It develops and sponsors emergency preparedness training, and coordinates counter-terrorism preparations for incidents involving hazardous substances. It provides emergency health and social services, and manages the National Emergency Stockpile System (NESS). Emergency preparedness and response activities are guided by the F/P/T Expert Group on Emergency Preparedness and Response, which is based on the Minister of Health’s Special Task Force on Emergency Preparedness and Response.
The Program strengthens Pan-Canadian emergency preparedness through the development of emergency operations plans, processes, and planning tools that support improved interoperability and response capabilities during emergencies.
The Program aims at protecting Canadians from geographical, biological and meteorological disasters that are either naturally occurring or human-made. Development of events such as workshops, table-top and command-post exercises helps to evaluate the capacity to respond to emergency situations and the effectiveness of existing plans and planning tools. It provides appropriate ongoing training to F/P/T and regional public health emergency response personnel and prepares them to adequately respond to public health emergencies including potential influenza pandemics.
The Program undertakes and supports relevant research, in addition to activities that support the use of evidence from relevant research fields to inform practice and policy decisions impacting health through knowledge dissemination, exchange and transfer (KDET) which includes the collection, review, and synthesis of evidence, risk assessment, creation of networks for knowledge exchange, creation of accessible and usable products and formats to communicate evidence, and development of mechanisms for dissemination.
The Program encompasses a range of public health intervention activities by which individuals, groups, and organizations improve their capacity and develop sustainable skills to identify, mobilize, and address public health problems. It includes activities such as community, institutional or professional based programming, workshops, and other educational events; the development of products, network development; and the provision of expertise. Emergency Preparedness develops plans and exercises that assist the Agency and its internal and external stakeholders to respond more efficiently and effectively during public health emergencies.
Emergency Preparedness develops training programs in health emergency management that permit all responders to respond to all types of emergencies. This activity aims at developing methodologies, courses, electronic and other tools, and skill sets to enhance emergency preparedness and response training.
The Program maintains the National Emergency Stockpile System which provides reserves of medical supplies and equipment strategically located in 1,300 P/T sites, and nine federal warehouses to enable timely responses which limit the potential harm to Canada from natural and human-made disasters. The Program also supports training of stakeholders to develop their capacities to deal with emergencies. The Program provides Health Emergency Response Teams (HERTs) to assist P/T and local authorities in providing emergency medical care during disasters. This program also coordinates with P/T and other federal authorities to manage population movement, medical assessment, and when necessary, medical isolation of travelers. Quarantine and other public health measures at entry and exit control points at major airports, including the provision of staff, protect against importation of infectious diseases of public health significance, safeguard the health of Canadian and international travelers, including visitors from falling prey to imported diseases.
The Program encompasses a range of public health intervention activities by which individuals, groups, and organizations improve their capacity and develop sustainable skills to identify and address public health problems. It includes community, institutional or professional based programming, workshops, and other educational events; the development of products; network development; and the provision of expertise. The program supports provinces and territories in response to natural and man-made disasters by providing emergency medical supplies and equipment (NESS, Emergency Response Assistance Plan for Infectious Substances, RG4) and medical surge capacity consistent with the National Framework for Health Emergency Management -Guideline for Program Development (National Office of Health Emergency Response Teams).
The Program also includes activities related to the development and drafting of regulations and legislation. As well, it includes initiatives related to monitoring, compliance with regulations, and the evaluation of their impact. Emergency Response provides quarantine services at major points of entry across Canada by enforcing the Quarantine Act to prevent the introduction of communicable diseases into and out of Canada and to assist in mitigating potential social and economic disruption.
In order to link the health sector’s emergency preparedness and response activities within the Government of Canada’s National Emergency Management Framework, the Agency is directly linked to Public Safety Canada. An important liaison function enhances the operational links with the Agency’s Emergency Operations Management System (EOMS) and the Government’s National Emergency Response System (NERS).
The Agency provides Pan-Canadian and international leadership through its surveillance, policy, and coordination of domestic and international efforts to ensure public health security.
The Program provides accurate and timely national and global public health event information to Canadian and WHO officials through the GPHIN. The Program also manages an EOC to facilitate the Agency and Health Canada situation/crisis management.
The Agency monitors imported diseases and foreign health outbreaks with potential to harm Canada, Canadians, and international travelers; mobilizes the Agency’s EOC system in times of national or international health emergencies to facilitate a coordinated and effective response, ensures a ready supply of expertise for evidence-based bio-safety, bio-containment, and bio-security interventions for possible biological accidents, and provides training, published guidance, and the enforcement of the Human Pathogens Importation Regulations on movement and use of dangerous pathogens in Canadian laboratories.
The Program manages ongoing, systematic use of routinely-collected health data for tracking and forecasting health events or determinants. Surveillance includes collection and storage of relevant data, data integration, analysis, and interpretation, production of tracking and forecasting products, publication and dissemination of those products, and provision of expertise to partners developing or contributing to surveillance systems.
The Program manages activities related to the development and drafting of legislation and regulations. It also manages initiatives related to monitoring, compliance with legislations and regulations, and the evaluation of policies and their impact. The program also manages the Health Portfolio’s Emergency Response Assistance Plan for Infectious Substances, RG4. The program prepares for transportation accidents involving RG4 materials. The plan includes Agency response personnel coordination of P/T response teams that respond to transport incidents anywhere in Canada.
The Program also verifies that Canadian Bio-containment laboratories are compliant with rigorous Canadian and international Bio-safety and Bio-security standards. The program minimizes the risk to Canadians from laboratories importing and working with highly dangerous pathogens for diagnostic, emergency preparedness and research purposes.
2008-09 | 2009-10 | 2010-11 |
44.1 | 44.8 | 45.2 |
2008-09 | 2009-10 | 2010-11 |
249 | 253 | 253 |
Canada must ensure a stronger public health system to keep Canadians healthy in an environment that presents many increasing threats to their health from widening social and economic inequalities to an increasing prevalence of chronic and infectious diseases. This public health system includes skilled public health practitioners, as well as the right information, knowledge and legal frameworks to support public health decisions.
Public health threats are indeed increasing. Global trade and personal mobility mean that viruses, contagious infections and foodborne illnesses can be transported from one continent to another in a matter of hours. There is also a rising incidence of once dormant infections such as Tuberculosis and polio, which are becoming a renewed threat to the health of Canadians. In addition, the persistent threat of a pandemic like Avian Influenza continues to loom.
Moreover, our primary health care system is strained, while unhealthy living habits and chronic disease continue to increase the demands for health services. Canadians facing social and economic challenges are also more likely to suffer health problems, and public health interventions must continue supporting targeted interventions for these populations.
The Public Health Agency of Canada is committed to strengthen and sustain its public health capacity to respond to the health needs of Canadians in their everyday lives and during a public health threat or emergency. The Agency will do that by focusing on building public health human resource capacity across Canada, establishing knowledge-based information systems and advancing its work in public health law and ethics.
Working with its national and international partners, the Agency will provide tools, practices, programs and understandings that support the public health system.
Needed public health capacity in Canada is not possible unless measures are taken to provide and maintain an adequate staff of highly qualified and motivated public health professionals. Such measures require comprehensive planning and cooperation at all level of governments, as well, as a multi-dimensional, integrated approach to public health human resources.
Working with its national and international partners, the Agency will deliver a wide range of programs covering the aspects of governance, programming, training, development and public health emergency support services. The human resource capacity (adequate people in the right places and with the necessary competencies) within the Agency and across Canada is a requirement for the Agency to fully achieve its strategic objectives.
In 2008-2009, the Agency will continue to support the Public Health Human Resources (PHHR) Task Group of the Public Health Network. The Task Group’s mandate was extended in November 2007 to address priorities identified for PHHR planning that were documented by the Advisory Committee on Health Delivery and Human Resources in the Pan-Canadian Framework for PHHR Planning: Building the Public Health Workforce for the 21st Century. Work will be undertaken in priority areas identified: Enumeration, Education and Core Competencies.
The Enumeration Working Group established under the PHHR Task Group is responsible for proposing pan-Canadian standards to guide the development of an information infrastructure for needs-based, system-driven public health workforce planning. The Enumeration Working Group anticipates:
Ultimately, this will increase all jurisdictions’ capacity to plan for the optimal number, mix, and distribution of public health skills and workers.
The Education and Core Competencies working groups will:
Continuous enhancement of skills is core to improving performance and ensuring a more effective public health workforce, which ultimately benefits the health of all Canadians. This is the focus of the Agency’s Skills Enhancement for Public Health Program, which offers an online continuing education environment for public health practitioners. In 2008-2009, the program will add three online modules to the current suite, increasing the total number to thirteen. This continuing education initiative helps public health practitioners develop and strengthen the knowledge, skills and attitudes needed to meet the core competencies for public health. The program will:
Recent interest from international agencies has highlighted the potential of the program to help strengthen public health systems and workforce capacity globally. The program will:
An adequate supply of qualified public health professionals entering practice is required to effectively support public health in Canada. The Agency, through its Public Health Scholarship and Capacity Building Initiative, will:
The Agency will work with the CIHR to award scholarships and fellowships to professionals with a focus on public health and to provide grants to support academic chairs in public health at a number of universities. These chairs will establish public health focused training opportunities, intervention research and linkages to local public health practice.
Through contribution agreements, the Agency will also support public health organizations to create training products and tools, such as nursing manuals, which will help professionals improve their work practices.
In order to fully deliver on its commitments, the Agency itself must have a competent workforce and an integrated workplan for professional development covering both the science and policy aspects of program delivery. Thus, the Agency will put in place the necessary measures to:
The Canadian Field Epidemiology Program (CFEP), now in its 33rd year, will continue to assign highly qualified staff to work with experienced epidemiologists, in order to broaden their skills. During their two-year training experience, Field Epidemiologists assist all jurisdictions and many institutions with outbreak investigation and control, cluster investigation and control, surveillance, risk assessment, evaluation, and other field epidemiology studies. The CFEP plays a major role in providing emergency public health service and response as these field epidemiologists are available and deployed both nationally and internationally as part of the Agency’s emergency response capacity.
The Agency’s new Canadian Public Health Service Program will hire a variety of public health professionals to address key gaps in provinces, territories, local jurisdictions and other public health organizations, as part of an expanded and strengthened public health work force. Public Health Officers in this program will directly serve their host organizations, while having the benefit of individualized learning plans supported by the Agency. The Program provides participants the combination of career-positive professional development and field experience in order to help develop the next generation of practitioners. Typical assignments will focus on planning, evaluation, surveillance and the management of diseases, risks to health, and emergency response, including, but not limited to, Avian or Pandemic Influenza.
Strengthened public health capacity requires robust knowledge-based information systems to support individuals and organizations in making decisions. Quite simply, it is critical that the collection, collation and distribution of information is meaningful (the right information), timely and efficient. This is one of the cornerstones of the Agency’s effort in strengthening public health capacity. Working with its F/P/T partners, the Agency makes tools, data, knowledge and best practices available to public health practitioners and strives to build consensus on common agreements for information sharing and for issues of mutual interest across jurisdictions.
The Agency’s GIS program is a recognized leader in its field due to its innovative virtual service delivery to public health practitioners. The geographic maps, charts and data available online to practitioners, assist them in fulfilling their public health responsibilities. Over the past several years, the Agency has seen a consistent increase in demand for these services.
Over the next three years, the Agency will:
Stronger public health requires an integrated multifaceted approach to develop, manage and sustain public health information systems. Canada Health Infoway was given a mandate to develop and implement a national surveillance system (Panorama) across all Canadian jurisdictions. The Agency’s Canadian Integrated Public Health Surveillance System (CIPHS) program will continue to support Panorama’s predecessor, the integrated Public Health Information Systems (iPHIS), in jurisdictions which are using it to carry on their relevant public health responsibilities, including public health emergency response. Jurisdictions require ongoing support for the iPHIS system until they can fully adopt and integrate Panorama.
The Agency’s Chief Public Health Officer (CPHO) will publish in 2008 the first annual report on the state of public health in Canada. This report will provide Canadians with a trusted source of information from Canada’s foremost officer responsible for the nation’s public health. Public health policy makers and program managers across Canada will see value in having a national perspective on public health issues. As part of fulfilling the Agency’s legislated mandate to report to Parliament on the state of public health in Canada, it will establish the ongoing capacity to prepare future reports.
Knowledge about the economic burden of illness in Canada is needed by all levels of government. The Agency will continue to:
The supply of public health information is critical to the success of the Agency. Key suppliers for some data include Statistics Canada, the Canadian Institute for Health Information and private sector data suppliers. The Data Coordination and Access Program (DCAP) continues to work with these partners to ensure the data available meets the needs of the Agency and that Agency staff have access to critical information, while respecting formal stipulations set by data suppliers. In 2008-2009 DCAP will continue these critical activities.
The Agency will continue working to strengthen the National Collaborating Centres for Public Health (NCCs). They carry an overarching mission to “build on existing strengths and create and foster linkages among researchers, the public health community and other stakeholders to ensure the efficiency and effectiveness of Canada’s public health system”. The NCCs:
The Agency, with the NCCs’ National Advisory Council, will continue to provide guidance and financial support to the NCCs.
The Agency strives to support its actions through integrated information and knowledge functions. Effective program delivery hinges on it. The Knowledge Translation Program aims to promote knowledge synthesis, transfer, exchange and application within the Agency and between the Agency and the public health system more generally. In 2008-2009, the program will:
Sharing of information during public health emergencies is a critical factor to safeguard the health of Canadians. An F/P/T Memorandum of Understanding (MOU) to this effect was developed by the Pan-Canadian Public Health Network Council. The Agency will continue to support the development and ratification of this MOU and to explore, review and undertake activities to determine the roles, processes and practices for sharing information between jurisdictions.
To support effective use of information systems, the Agency will:
A key activity in this regard will be to support an Agency-wide integrated surveillance strategy.
All public health authorities are concerned about new and re-emerging infectious and chronic diseases such as SARS, CA-MRSA,1 pandemic influenza, Types 1 and 2 diabetes and MDR-TB2. They remain equally concerned about refining jurisdictional roles and responsibilities and the need to ensure that the most modern legislative tools are available to protect public health. The Agency’s special role is to lead the response to these challenges specifically by enhancing public health preparedness through improving legal and ethical frameworks in collaboration with all relevant stakeholders.
In 2007, Canada’s Health Ministers identified Pan-Canadian collaboration on these issues as critical in meeting this challenge. At the forefront in these efforts, the Agency undertakes and facilitates activities to review, analyze and assess laws and regulations intended to protect health and safety in order to increase awareness and understanding of the law as a public health intervention tool, and the importance of ethics as underpinning effective public health decision-making.
1 Community Acquired Methicillin Resistant Staphylococcus Aureus
2 Multi-Drug Resistant Tuberculosis
In 2008-2009, the Agency will continue to:
Following the ground-breaking success of Canada’s first-ever Canadian Conference on the Public’s Health and the Law in 2006, the Agency will host a follow-up conference in 2009. This will further support the activities of the Pan-Canadian Public Health Law Improvement Network, whose aim is to share information and assist with analysis in public health law and develop additional public health legal capacity.
Through the Public Health Ethics Working Group, the Agency will:
Strategic Outcome: Healthier Canadians, reduced health disparities, and a stronger public health capacity |
||||
Program Activity | Planned Spending (in millions of $) |
Alignment to Government of Canada Outcome Area |
||
2008-09 | 2009-10 | 2010-11 | ||
Health Promotion | 203.5 | 200.8 | 197.3 | Healthy Canadians |
Chronic Disease Prevention and Control | 69.0 | 69.0 | 69.0 | Healthy Canadians |
Infectious Disease Prevention and Control | 234.9 | 275.6 | 239.0 | Healthy Canadians |
Strengthen Public Health Capacity | 44.1 | 44.8 | 45.2 | Healthy Canadians |
Emergency Preparedness and Response | 39.1 | 42.4 | 39.0 | Safe and Secure Communities |
The Public Health Agency of Canada directly contributes to two Government of Canada outcomes:
1. Healthy Canadians
Four of the Agency’s Program Activities support this outcome area:
2. Safe and Secure Communities
One of the Agency’s Program Activities, Emergency Preparedness and Response, directly supports the “Safe and Secure Communities”Government of Canada outcome. The Agency plays an important role in reducing the threat of infectious diseases and chemical and biological agents, and accordingly contributes to the safety of Canadian communities.
The Agency also has an influence on two other Government of Canada outcomes, as follows:
Having launched its first Sustainable Development Strategy (SDS) during 2007-2008, fiscal year 2008-2009 represents the second year of implementation of the first Public Health Agency of Canada SDS. In this Strategy, the Agency has committed to the goals of incorporating sustainable development considerations into the planning and implementation of its activities, ensuring that the Agency conducts its operations in a sustainable manner, and building capacity to implement the Strategy. The commitments made in the SDS will advance the Agency’s strategic objective of healthier Canadians, reduced health disparities, and a stronger public health capacity, and by doing so will support the Governments priority of reducing patient wait times. Because sustainable development (SD) is a comprehensive and balanced concept, it recognizes the links between the economy, the environment and social well-being, including health. Sustainable development aims to improve human health and well-being to enable Canadians to lead economically productive lives in a healthy environment while sustaining the environment for future generations.
In order to accomplish these balanced objectives, the Agency is committed to integrating best practices for SD into its decision making, processes and operations. It will also be working closely with the P/T and other partners to achieve sustainable development, keep Canadians healthy, and help reduce pressures on the health care system. At the same time, the Agency recognizes SD is a long-term journey. It is one that the Agency is committed to pursuing over the three-year planning period.
The Agency’s SD contributions not only support its SDS and its public health mandate, they also support federal SD goals, such as sustainable communities, SD and use of resources, reducing greenhouse gas emissions, targets of the Office of Greening Government Operations (GGO), and strengthening federal governance and decision-making to support SD.
During 2008-2009 the Agency will make progress toward several SDS deliverables including:
During 2008-2009, the Agency will support these initiatives and sustainable development by working with staff to support them in understanding how SD applies to their work. The Agency SDS can be found at: http://www.phac-aspc.gc.ca//publicat/sds-sdd/sds-sdd2-a_e.html
SDS Agency Goal 1: Incorporate SD considerations into the planning and implementation of Agency activities | ||
2. Federal SD goal, including GGO goals (if applicable) | 3. Performance measurement from current SDS | 4. Department’s expected results for 2008-09 |
Sustainable communities – communities enjoy a prosperous economy, a vibrant and equitable society, and a healthy environment for current and future generations | % Solicitations that address SD issues % Eligible employees that received SD training % Funding that involves SD criteria # Solicitations where SD is mentioned |
Target 1.1.1: Include SD considerations in all Population Health Fund solicitation documents by December 2009 Milestone: Training made available to Agency staff on sustainable development concepts to enable them to deliver on this target |
# Funded projects with SD elements # Families and/or individuals reached through projects either directly or indirectly |
Target 1.1.2: By March 31, 2008, review outcomes of Population Health Fund projects funded by the Quebec Region to determine project SD contributions Milestone: Report on findings on an annual basis, the first report by March 31, 2008 |
|
# Education Programs delivered # Active surveillance programs developed and implemented # Presentations given # Articles published # Health care providers and community individuals accessing the education program # Recognitions received for research # Viable suggestions to improve treatment # Case control studies # Active surveillance programs |
Target 1.2.2: As a partner in the Northern Antibiotic Resistance Partnership, study and contribute to the development and delivery of an education program on infectious organisms that are becoming increasingly resistant to commonly used antibiotics for both health care providers and community individuals by December 31, 2008 Milestone: Develop and deliver an education program aimed at both health care providers and individuals in the community in an attempt to reduce the prevalence of AROS in the community by December 31, 2008 |
|
Sustainable development and use of natural resources |
Availability of rapid molecular typing system Availability of phage therapy for E coli 0157:H7 in food animals Reporting on results of research activities at the Laboratory for Foodborne Zoonoses Reporting on activities undertaken at the high-performance disease modeling and Health Geographic Information Systems (GIS) Laboratory |
Target 1.2.3: Contribute to reducing the risks to human health from foodborne and waterborne diseases arising from animals and the agro-environment through knowledge generation, knowledge synthesis and evidence-based interventions Milestones: 1. Usage of the high performance disease modeling and Health GIS laboratory Saint-Hyacinthe) for spatial analysis and geomatics for specific health risks associated with foodborne and waterborne infections (on-going but reported annually, 3 times by March 31, 2010) 2. Communication of the integrated results of surveillance programs (CIPARS annually and C-EnterNet report on pilot study findings by March 2009) 3. Communication of the results of knowledge synthesis and translation for specific public health risks investigated, and provide evidence to policy-makers for informed decision-making (ongoing) |
# Community-based groups receiving funding # Community-based groups receiving strategic guidance on programming # Children and families receiving program benefits |
Target 1.2.4: Contribute to the sustainability of communities by administering community-based programs directed at women, children and families living in conditions of risk, through the Community Action Program for Children, the Canada Prenatal Nutrition Program and Aboriginal Head Start in Urban and Northern Communities Milestone: March 2008 - Community Programs Annual Report |
|
% Canadians reporting participation in physical activity % Canadians reporting healthy eating % Canadians reporting healthy weight |
Target 1.2.5: With provincial / territorial partners, help to increase the proportion of Canadians who participate in physical activity, eat healthier diets and have healthy weights by 20% by the year 2015 Milestone: By March 2010, evaluate progress toward the federal provincial healthy living target for input to evaluation of the pan-Canadian Healthy Living Strategy |
|
# Teaching positions funded # Workshops conducted, joint activities # Continuing education strategies established # Community-oriented applied public health research programs established |
Target 1.2.6: Each recipient university establish, by 2009, a continuing education strategy aimed at local public health workers and a community-oriented applied public health research program |
SDS Agency Goal 2: Ensure that the Agency conducts its operations in a sustainable manner | ||
2. Federal SD goal, including GGO goals (if applicable) | 3. Performance measurement from current SDS | 4. Department’s expected results for 2008–09 |
Sustainable development and use of natural resources | % Material managers trained # Training courses offered # Participants in training courses % of acquisition card holders that have received green procurement training |
Target 2.1.1: Provide procurement training to 75% of material managers and integrate green procurement into training for acquisition cards by December 31, 2008 Milestone: Train existing Acquisition Card holders by December 21, 2008 |
% Inventory that is ENERGY STAR-compliant # LCD monitors vs CRT monitors % LCD monitors % Network printers vs regular printers % Printers with duplex capacity % Stand-alone printers replaced % Stand alone printers replaced with group printers % Group printers moved to well-ventilated areas |
Target 2.1.2: Meet the Government of Canada standards for purchase and by March 31, 2010 meet the guidelines for operations of office equipment Milestones: 1. All new desktop computers, computer monitors and printers or multifunction devices (combined printer-scanner-fax) purchased meet the environmentally friendly ENERGY STAR standard 2. Individual printers to be authorized only if the individuals print confidential documents on a regular basis or are physically disabled 3. Replacement of IT equipment each year based on the 3 year evergreening standard upon receipt of evergreening funds |
|
# Baselines of the Agency’s procurement patterns established # Report on tracking options |
Target 2.1.3: Establish a baseline of the Agency’s green procurement patterns and explore options to develop an effective, efficient and affordable green tracking system by December 31, 2008 Milestone: Compile report and make recommendations on green procurement tracking options by December 31, 2008 |
|
# Times telephone, video and web conferencing services used % Awareness of green travel options among Agency employees # People attending information sessions on green travel options % Employees using green travel options % Employees using alternative modes of transportation % Employees using telephone, video and web conferencing services |
Target 2.1.4: Increase awareness of green travel options to 50% of all Agency employees by March 31, 2009 Milestones: 1. Develop a Green Travel Options Awareness Program by December 31, 2008 2. Include module related to Green Travel Options Awareness in survey of Agency employees by January 31, 2009 3. Include results of employee awareness of Green Travel Options in Report on Employee Awareness of Sustainable Development by March 31, 2009 |
|
# Tools developed for effective hazardous waste monitoring and reporting | Target 2.2.1: By March 31, 2010, institute effective hazardous waste monitoring and reporting Milestones: 1. As of April 1, 2008 and each year thereafter, annual review of hazardous waste volumes in the Laboratory for Foodborne Zoonoses and the National Microbiology Laboratory 2. Develop and roll out a database for the Agency and Health Canada for monitoring the generation of hazardous waste and recycling opportunities, as a tool that can identify opportunities for more sustainable use and disposal of chemicals and other materiels. |
|
Reduce greenhouse gas emissions | % Reduction in water and energy consumption | Target 2.3.1: Improve energy efficiency and reduce water consumption in Agency-owned laboratory buildings under normal operating conditions by 2% by FY 2009-2010, using FY 2005-2006 energy and utility management data as the baseline Milestones: 1. Building Management Plans for Agency-owned building reviewed annually to ensure that planned projects, where applicable, will reduce energy consumption by March 31, 2010 2. Report annually on the effectiveness of preventative maintenance and building improvements on usage of non-renewable resources, comparing building performance review of energy/utility management to the baseline data of 2005-06 by March 31, 2010 |
SDS Agency Goal 3: Build capacity to implement Goals 1 and 2 | ||
2. Federal SD goal, including GGO goals (if applicable) | 3. Performance measurement from current SDS | 4. Department’s expected results for 2008–09 |
Strengthen federal governance and decision-making to support sustainable development | # Strategic Environmental Assessments (SEAS) conducted for new policies, plans and programs % Policy, plan and program proposals entered in the system that have completed SEAS, on an annual basis |
Target 3.1.1: Track SEAS of policy, plan and program proposals by March 30, 2008 |
% Agency employees who understand how SD applies to their work # Policy implemented by March 31, 2010 |
Target 3.2.1: Develop and implement a Sustainable Development Policy by March 31, 2010 Milestones: 1. Consultation with staff by October 2008 regarding link between SD and Agency mandate for public health 2. Mapping of how Agency policies, programs and operations interact with SD principles and initiatives by November 20, 2008 3. Proposal by December 30, 2008 on the Agency’s role in sustainable development and on how an SD policy would help guide staff to implement SD within the Agency |
|
# Provinces where the GIS services are available to public health professionals % Increase in the number of public health professionals using the GIS services between June 2006 and December 2008 |
Target 3.2.2: Provide a sustained and accessible GIS infrastructure for public health and SD practice Milestone: December 2008, Offer GIS infrastructure services to 13 provinces and territories |
|
# Progress reports submitted per year SD listed as a standing item on Management Committee meeting agenda # of SD discussions in Management Committee meetings |
Target 3.3.1: Report progress to management on SD goals and objectives twice a year Milestone: Review overall progress toward SD goals and objectives by January 30, 2009 |
|
# Strategic, human resources and planning documents in which SD considerations are integrated | Target 3.3.2: Integrate SDS commitments into the Agency’s key planning and reporting processes by March 31, 2010 |
|
# Budget review processes that consider SD principles % Budget review processes that consider SD principles |
Target 3.3.3: Consider SD principles in all budget review processes undertaken within the Agency by March 31, 2010 Milestones: 1. Contribute to the 2-year Base Budget Review 2. Assess base budget review findings for SD gaps and opportunities and provide SD expertise for recommendations by June 30, 2008 |
|
Not linked to a federal SD goal | # Databases developed/integrated # Tools developed # Collaborations # Meetings # Presentations delivered # Articles published # Documents created # Educational/training sessions delivered # Recognitions received # Viable suggestions to improve treatment # Fingerprinted strains of antimicrobial-resistant community- or-hospital acquired organisms |
Target 1.2.1: Genetically fingerprint anti-microbial resistant strains to describe patterns in human antimicrobial use and antimicrobial resistance by December 31, 2009 Milestone: Support the development of a risk analysis framework for antimicrobial use in agriculture and humans by December 31, 2008 |
# Awareness-building activities % Agency employees who understand their responsibilities in relation to SD |
Target 3.1.2: 75% of Agency employees understand how SD applies to their work by March 31, 2009 Milestones: 1. Beginning in September 2006, ongoing communications to staff regarding Sustainable Development through a variety of media (submissions to Just the PHACs, skit or a stunt during United Way fund raising, presentations to Management Committees or at retreats) 2. Work with Communications to develop an Internal Communications Plan for each year of the strategy 3. Use this information in planning for SD in the Agency, including the next round of SDSs (Undertaken by January, 2010) 4. Conduct consultations on SD with staff of each directorate, centre, lab, region etc by September 2008 and report on them to Management Committee 5. Commitment by Human Resources (HR) Directorate to encourage staff participation in Earth Day activities 6. Commitment by Human Resources Directorate to encourage staff to participate in Environment Week activities 7. Human Resources Directorate commitment to discuss whether or not awareness among HR staff has increased and to report results to Office of Sustainable Development 8. Use this information in planning for SD in the Agency, including the next round of SDSs (Undertaken by January 2010) |
The following financial tables can be found on the Treasury Board of Canada Secretariat (TBS) website at http://www.tbs-sct.gc.ca/rpp/2008-2009/info/info-eng.asp
The Public Health Agency of Canada recognizes that strategic and developmental initiatives are required to support the achievement of its priorities and advance the work of improving public health. Since its inception, the Agency has undertaken a number of activities to fulfill its role as a voice for public health, to define its structural needs and to establish the necessary elements, to build new and expand relationships, and to explore new avenues for improving the public health system in Canada.
Public health is a responsibility shared across governments and other stakeholders. In order to achieve tangible results, the Agency works closely and cooperatively with all of its partners to provide a cohesive, national approach to public health. The Agency is working to strengthen relations P/T and international authorities, to facilitate working relationships across sectors and to ensure a comprehensive engagement of all stakeholders. Recognizing the critical importance of evidence-based programs and policies, the Agency is working to develop its internal capacity for knowledge generation and translation, as well as mechanisms for information sharing and exchange with external partners.
In light of the continuing poor health status of First Nations, Inuit and Métis relative to the broader Canadian population, and with the understanding that First Nations, Inuit and Métis are distinct and diverse, the Agency continues to take steps towards implementing commitments under its 2007-2012 Strategic Plan and its June 2007 response to the Standing Senate Committee on Social Affairs, Science and Technology. With its commitments and the public health needs of Aboriginal Peoples in mind, the Agency will continue to build on existing policy and program initiatives, including its increased strategic policy capacity in this area, and will pursue the following actions over the three-year planning period in order to further strengthen its policy foundation, capacity and focus on First Nations, Inuit and Métis public health:
These actions will serve to further develop a network of relationships, clarify and solidify the Agency’s role in and approach to First Nations, Inuit and MĂ©tis public health, and better position the Agency and the Government of Canada to effectively address Aboriginal public health issues and, more broadly, the determinants of Aboriginal Peoples’ health.
Public health is a critical international issue with economic, security and development dimensions. While infectious diseases continue to exact a high human toll in lives lost, particularly among children, chronic and non-communicable diseases now form the majority of the burden of disease and premature deaths in the world, including in a significant number of developing countries. The Agency will continue to use multilateral and regional organizations as well as bilateral relationships to confront these global public health challenges and build upon past successes. During the planning period, the Agency will take a leadership role in supporting international initiatives that build capacity in key areas and influence global policies that are in the interests of public health in Canada.
In 2008-2009, the Agency will further an international health strategy and an organizational approach for managing international activities. In addition to supporting Canada’s domestic public health goals, this investment provides a more solid foundation for strategic international initiatives to strengthen global public health security; to strengthen international efforts to build capacity in public health systems; and to reduce the global burden of disease and global health disparities – three interconnected and mutually supportive objectives. Strengthening international public health infrastructure enhances public health globally and is integral to reducing the global disease burden and improving global public health security. This area is demanding new approaches to ensure that a critical line of defence is maintained to protect Canadians against many current and emerging public health and other health-related threats.
The Agency’s investments in 2008-2009 will expand its capacity to implement its international health strategy and strengthen Canada’s links in the international public health arena. They will enable Canada to meet its international obligations and share more public health expertise with global partners. During the planning period, the Agency will also continue to develop and strengthen relationships with bilateral and multilateral partners and institutions, such as the WHO (a Government of Canada strategy with regard to this relationship is currently being developed), the PAHO, the OECD and the International Union for Health Promotion and Education. The resulting exchanges of information will improve the Agency’s domestic work by allowing the best practices of other countries to be reflected in the development of Agency policies.
Canadians increasingly recognize the linkages between health and the environment. Novel measures to improve air quality in Canada and stricter environmental standards, with appropriate enforcement, have been identified as key government priorities. Changes in climate, air and water quality, wildlife habitats and other aspects of the environment all have an impact on the health of Canadians. The Agency is committed to developing a strong and comprehensive policy on possible public health effects stemming from the physical environment. The Agency is well positioned to work horizontally, with other federal players and partner organizations, to incorporate a public health perspective in the broader health and environment agenda. As a member of the Health Portfolio, the Agency will continue to work closely with Health Canada’s Healthy Environments and Consumer Safety Branch on addressing the links between health and the environment. The Agency will also provide public health expertise to other federal partners such as Environment Canada, Natural Resources Canada, and Indian and Northern Affairs Canada.
The 2005 launch of the Pan-Canadian Public Health Network was an important, strategic step in strengthening public health capacity across Canada. In establishing the Network, F/P/T Ministers of Health created a mechanism for multilateral sharing and exchange among F/P/T public health institutions and professionals. This new, more collaborative approach to public health policy and initiatives is critical during public health emergencies, and will also assist Canada in establishing a more efficient approach to addressing serious public health issues.
The Network will continue to focus on joint strategies and action in the following six public health areas: communicable disease control; emergency preparedness and response; public health laboratories; public health surveillance and information; non-communicable disease and injury prevention; and population health promotion.
Over the planning period, the Agency will continue to capitalize on investments made in the Pan-Canadian Public Health Network. Key planned initiatives for the Network over this period include:
The Agency is also exploring opportunities to include expertise in Aboriginal public health in the work of the Network.
The Agency will continue to enhance and augment its policy capacity in order to strengthen its public health leadership and its contribution to the priorities of the Health Portfolio and the health-related priorities of other government departments. By doing so, the Agency will be in a better position to identify, coordinate, and bring forward high-quality strategic proposals and options for the consideration of the Minister of Health and Cabinet, enhance policy synergies, and develop and make use of a variety of levers, partnerships, and innovative delivery mechanisms. The development of policies will better integrate results and value-for-money considerations. During the planning period, steps will be taken to further develop the Agency’s policy capacity within program branches while maintaining and enhancing its core policy functions within the Strategic Policy Directorate.
The Agency launched its first Strategic Plan 2007-2012 on September 13, 2007. This comprehensive plan promises to enhance the management and effective delivery of the Agency’s programs.
The next step is to identify concrete measures that will be taken to deliver on these priorities over the next five years. Managers are being encouraged to hold all-staff retreats to discuss what the Agency needs to do to make the Plan a reality.
As well, to move the five-year strategic plan forward, an annual corporate business planning process aligns the Agency’s human capital with its strategic and business goals. The broad strategic directions and Agency priorities identified in the strategic plan, coupled with the implementation strategy and accountability mechanisms set out in the Corporate Business Plan, will improve performance and organizational success through integrated planning and efficient action.
As part of the due diligence undertaken as its organizational structure is evolving, the Agency is developing a corporate risk profile. This involves taking stock of the operating environment and the organization’s capacity to deal with key high-level risks linked to the achievement of corporate objectives. During a series of workshops held early in 2006, risks that could prevent the Agency from meeting its objectives were identified and assessed with a risk-assessment tool that has both qualitative and quantitative elements. The resulting risk profile will inform senior officials on the prevailing departmental perspective on risks inherent to the Agency’s mandate and risks emerging from the changing operating environment, and how these risks are to be mitigated, managed and communicated.
This is the first step in incorporating an integrated risk-management framework into the Agency’s daily operational practices. The adoption of such a framework supports the federal agenda of modernizing management practices and supporting innovation through more responsible risk-taking.
The Agency launched its Strategic Risk Communications Framework in March 2007, and training and implementation are under way. Strategic risk management and communications provides support for informed decision-making and communications that helps stakeholders, and ultimately all Canadians, make well-informed decisions on key public health issues, and foster the confidence of Canadians in the Agency by serving as a foundation for integrated risk management in public health.
The Agency’s Communications Directorate has been trained in the Framework and is working with program managers and policy makers to implement it as a component of risk management on a variety of issues. Multi-disciplinary teams from across the Agency and the health portfolio have been established and the Framework is being used by those teams to guide a risk management and communications approach to key files. Training has been expanded to include other groups at the Agency, such as the Office of Public Health Practice, and groups at Health Canada. In addition, the Agency is investigating how to facilitate a wider roll-out of training to other departments to assist them in risk management.
The Public Health Agency of Canada’s Business Continuity Planning (BCP) program allows critical services or products to be continually delivered to clients regardless of any major disruption of normal activities (e.g. due to a disaster or major outbreak of disease), instead of being focused on resuming business after critical operations have ceased or recovering after a disaster. A critical service is one whose compromise in terms of availability or integrity would result in a high degree of injury to health, safety, security or economic well being of Canadians or to the efficient functioning of the Government of Canada. The Agency is committed to having a solid BCP program that responds to all hazards.
The BCP includes as an annex, a BCP in the event of an Influenza Pandemic which outlines the Agency’s response in the event of such an emergency. It would be used to determine the resources needed to maintain the critical services and approved priorities, as well as to examine the specific skill sets required. This annex also includes a management replacement plan, as well as avenues to obtain resources.
The Agency conducted a test of its BCP in the event of an Influenza Pandemic, March 2007, as a table-top exercise. Recommendations that resulted from the exercise are being implemented over the coming months and another test of the BCP for the Agency is tentatively scheduled for fiscal year 2008-2009.
The Agency’s BCP program is maturing and a greater understanding of the needs of the Agency has been achieved. It is with this understanding that a number of changes are anticipated over the next 24 months to develop a comprehensive set of plans that match the strategic directions of the Agency.
A strong regional presence ensures that the Agency can provide leadership and promote coordinated action on population and public health across the country and achieve its strategic objectives and priorities. Agency Regional Offices connect and support stakeholders, including those outside the health sector, to take action on national priorities, gather public health information and build on resources at the regional, provincial and district levels.
The Agency will continue to expand the role and effectiveness of its regional operations, promoting better alignment and coherence between regional and national levels with respect to structure, governance, priorities and accountability. Agency Regional Offices will also continue to provide information and strategic advice from regional perspectives to influence and participate in decision-making, innovate and respond to emerging health issues and opportunities in the regions and facilitate action across the country to strengthen the public health system.
Grants and Contributions (Gs and Cs) are a mechanism within programs that assist the Agency in fulfilling its mandate and public policy objectives by entering into funding relationships with public, private, volunteer and not-for-profit organizations that are working to promote and protect the health of Canadians. These include initiatives that deliver health promotion and disease prevention programs, undertake research, public policy development, surveillance, knowledge synthesis and exchange initiatives, strengthen public health capacity and develop strategies and networks to build healthy communities and respond to emerging public health issues.
The Program Management Committee (PMC), a permanent senior management committee established in 2006, is mandated by the CPHO to provide direction and oversight of the Agency’s programs and related Gs and Cs activities. This Committee is responsible for ensuring that Agency programs are closely aligned with the Agency’s public health policy objectives, enhance Agency capabilities and accountability and are managed with care to achieve results for Canadians.
Over the next year, the PMC will work with Agency programs and initiatives to implement recommendations of Gs and Cs reviews, including strengthening the management, oversight and effective delivery of Gs and Cs funds.
The Agency continues to develop the corporate infrastructure to deliver and support its day to day business. On April 1, 2007, the newly created Access to Information and Privacy (ATIP) Division assumed responsibility for the ATIP function. During this period, to improve the Agency’s ability to respond to ATIP requests, the Division is undertaking staffing, developing ATIP policy, and launching an Agency-wide ATIP training and awareness program.
In May 2007, as part of the strategy to implement the Treasury Board (TB) Policy on Internal Audit, the CPHO and the Agency’s Executive Committee approved the revised Risk-Based Audit Plan (2007-2008 to 2009-2010). The audit plan describes the audit projects that will be undertaken by the Audit Services Division. The audit reports will be made available to the public on the Agency’s web site. Observations and information regarding the audits will be included in the Agency’s future Departmental Performance Reports (DPR) and Reports on Plans and Priorities (RPP).
The Chief Audit Executive established policies and procedures to guide the internal audit function. In October 2007, as required by the TB Policy on Internal Audit Directive on Departmental Audit Committees, the Agency and TBS appointed its external members for the newly established Audit Committee. The audit committee met for the first time in November 2007 and will meet four times a year. The audit committee is overseeing the conduct of internal audits and is providing the CPHO with the assurance on the adequacy of internal controls, particularly by assessing controls over financial management and financial reporting and by assessing the delivery of programs and activities with due regard to economy, efficiency and effectiveness.
The Centre for Excellence in Evaluation and Program Design (CEEPD) provides corporate leadership, independent advice and guidance, and promotes effective, high-quality and consistent performance monitoring, measurement and evaluation practices across Agency programs, policies and initiatives.
In 2007, the CEEPD developed the first five-year (2007-2012) risk-based evaluation plan for the Agency, which was approved by the Agency’s Evaluation Advisory Committee and the CPHO. The evaluation plan will be updated annually to reflect changes in Agency priorities and new evaluation work scheduled, and the evaluation reports will be made available to the public through the Agency’s web site. Observations and information regarding the evaluations are included in the Agency’s DPRs and RPPs.
In 2008-2009, the CEEPD will be focussing its efforts on developing and implementing an Agency Evaluation Policy, and addressing the requirements in the new TBS Evaluation Policy, including the requirement to evaluate all grants and contributions programs on a five-year cycle. The CEEPD is also seeking to establish an Agency community of practice for evaluators and those interested in evaluation/knowledge development and exchange, to regularly engage in opportunities to share, learn and improve their own professional and organizational performance.
A government-wide process to facilitate the full implementation of the Government of Canada’s Management, Resources and Results Structure Policy began in 2006-2007 and continued during 2007-2008. The Agency made modifications to its SO and its PAA, and worked on describing its governance structures and developing its first official performance measurement framework.
During 2008-2009, the Agency will develop implementation strategies and quality assurance processes, particularly for its performance measurement framework with a view to strengthening transparency and accountability within the Agency and in reporting to Parliament and the public.
The Agency is continually involved in an evolving framework of partnerships and collaborations at many levels. Our range of partners includes other federal departments and agencies, P/T governments, stakeholders, as well as international organizations. As indicated in the Agency’s Strategic Plan, the Agency is striving toward a more inclusive and comprehensive approach to engaging stakeholders as full partners in shaping and delivering results. The Agency will launch a broader strategic approach to stakeholder relations management. This approach will involve strengthening the Agency’s relationships with its partners, resulting in better engagement in coordinated efforts to advance shared public health objectives on common priorities.
The following is a summary of the transfer payment programs for the Public Health Agency of Canada in excess of $5 million per fiscal year. All the transfer payments shown below are voted programs.
2008-2009
2009-2010
2010-2011
1. Name of transfer payment program: Aboriginal Head Start Initiative | ||||
2. Start date: 1995-1996 | 3. End date: Ongoing | |||
4. Description: Contributions to incorporated, local or regional non-profit Aboriginal organizations and institutions for the purpose of developing early intervention programs for Aboriginal pre-school children and their families. | ||||
5. Strategic outcome: Healthier Canadians, reduced health disparities and a stronger public health capacity. | ||||
6. Expected results: To provide Aboriginal pre-school children in urban and northern settings with a positive sense of themselves, a desire for learning, and opportunities to develop successfully as young people. This program helps to reduce the risk of health disparities experienced by vulnerable children and families living in conditions of risk through increased community capacity, by helping participants make healthy choices and by promoting multi-sectoral partnerships. | ||||
(in $ millions) | 7. Forecast Spending 2007-08 |
8. Planned Spending 2008-09 |
9. Planned Spending 2009-10 |
10. Planned Spending 2010-11 |
11. Program activity (PA): Health Promotion | ||||
12. Total contributions | 26.7 | 26.7 | 26.7 | 26.7 |
13. Total (PA) – Health Promotion | 26.7 | 26.7 | 26.7 | 26.7 |
14. Planned evaluations: A summative evaluation was completed in 2006-2007 and was approved by the Agency’s Evaluation Advisory Committee and the Chief Public Health Officer. Annual process evaluations will continue to be conducted and efforts to design a study looking at longer-term impacts of AHS are in progress. Regions will continue to undertake regionally-specific evaluation activities, as required. | ||||
15. Planned audits: A performance audit of this Program is scheduled in 2008-2009. Any audit of Recipients is done at the Program level. |
1. Name of transfer payment program: Community Action Program for Children | ||||
2. Start date: 1993-1994 | 3. End date: Ongoing | |||
4. Description: Contributions to non-profit community organizations to support, on a long term basis, the development and provision of preventive and early intervention services addressing the health and development challenges experienced by young children at risk in Canada. | ||||
5. Strategic outcome: Healthier Canadians, reduced health disparities and a stronger public health capacity. | ||||
6. Expected results: To enhance community capacity and to respond to the health and development needs of young children and their families who are facing conditions of risks through a population health approach. To contribute to and improve health and social outcomes for young children and parents/caregivers facing conditions of risk, and to continue partnership with multi-sectors in the community. | ||||
(in $ millions) | 7. Forecast Spending 2007-08 |
8. Planned Spending 2008-09 |
9. Planned Spending 2009-10 |
10. Planned Spending 2010-11 |
11. Program activity (PA): Health Promotion | ||||
12. Total contributions | 48.8 | 48.8 | 48.8 | 48.8 |
13. Total (PA) – Health Promotion | 48.8 | 48.8 | 48.8 | 48.8 |
14. Planned evaluations: A formative evaluation is scheduled for 2007-2008 and a summative evaluation is scheduled for 2008-09. Lessons learned will be used to guide future evaluation and planning of CAPC. Regions will continue to conduct regionally-specific evaluation activities, as required. | ||||
15. Planned audits: A performance audit of this Program is scheduled in 2008-2009. Any audit of Recipients is done at the Program level. |
1. Name of transfer payment program: Canada Prenatal Nutrition Program | ||||
2. Start date: 1994-1995 | 3. End date: Ongoing | |||
4. Description: Contributions to non profit community organizations to support on a long term basis, the development and provision of preventive and early intervention services addressing the health and development challenges experienced by young children at risk in Canada. | ||||
5. Strategic outcome: Healthier Canadians, reduced health disparities and a stronger public health capacity. | ||||
6. Expected results: To reach the intended audiences: e.g. women living in challenging circumstance such as poverty, poor nutrition, teenage pregnancy, social and geographical isolation, recent arrival in Canada, alcohol or substance use and/or family violence. To build an evidence base for policies, programs and practices. | ||||
(in $ millions) | 7. Forecast Spending 2007-08 |
8. Planned Spending 2008-09 |
9. Planned Spending 2009-10 |
10. Planned Spending 2010-11 |
11. Program activity (PA): Health Promotion | ||||
12. Total contributions | 24.9 | 24.9 | 24.9 | 24.9 |
13. Total (PA) – Health Promotion | 24.9 | 24.9 | 24.9 | 24.9 |
14. Planned evaluations: A summative evaluation is scheduled for 2008-2009 and will measure the reach and retention, relevance and impact of the program to the target group. Regions will continue to conduct regionally-specific evaluation activities, as required. | ||||
15. Planned audits: A performance audit of this Program is scheduled in 2008-2009. Any audit of Recipients is done at the Program level. |
1. Name of transfer payment program: Population Health Fund | ||||
2. Start date: 1999-2000 | 3. End date: Ongoing | |||
4. Description: Provides grants and contributions to Canadian voluntary not-for- profit organizations and educational institutions to increase the ability of communities and individuals to improve their health by developing models, increasing knowledge for programs and policy, and by building collaborate approaches which address the determinants of health. | ||||
5. Strategic outcome: Healthier Canadians, reduced health disparities and a stronger public health capacity. | ||||
6. Expected results: The Population Health Fund’s expected result is to increase community capacity for action on or across the determinants of health. The goal is realized by the following objectives: 1) develop, implement, evaluate and disseminate community-based models of applying the population health approach, 2) increase the knowledge base for program and policy development on population health, and 3) increase partnerships and develop intersectoral collaboration to address specific determinants of health or combinations of determinants. | ||||
(in $ millions) | 7. Forecast Spending 2007-08 |
8. Planned Spending 2008-09 |
9. Planned Spending 2009-10 |
10. Planned Spending 2010-11 |
11. Program activity (PA): Health Promotion | ||||
12. Total grants | 11.4 | 11.4 | 11.4 | 11.4 |
12. Total contributions | 3.3 | 3.3 | 3.3 | 3.3 |
13. Total (PA) – Health Promotion | 14.7 | 14.7 | 14.7 | 14.7 |
14. Planned evaluations: An evaluation was completed in 2006-2007 which examined the delivery management stream of the Population Health Fund, and an outcome evaluation is scheduled for 2007-2008. Regions evaluate their respective programs at regular intervals. All regions will be using the Program Evaluation Reporting Tool (PERT), an evaluation tool that measures common indicators and provides a consistent approach to program measurement and data collection, as well as other formats as appropriate. | ||||
15. Planned audits: A performance audit of this Program is scheduled in 2007-2008. Any audit of Recipients is done at the Program level. |
1. Name of transfer payment program: The Federal Initiative to Address HIV/AIDS in Canada | ||||
2. Start date: 1998-1999 | 3. End date: Ongoing | |||
4. Description: In January 2005, the launch of the Federal Initiative to Address HIV/AIDS in Canada signalled a renewed and strengthened federal role in the Canadian response to the disease. The G and C funds support front-line organizations to contribute to the prevention of HIV/AIDS, and to promote increased access to diagnosis, care, treatment and support for people affected by the disease. | ||||
5. Strategic outcome: Healthier Canadians, reduced health disparities and a stronger public health capacity. | ||||
6. Expected results: Projects funded at the national and regional levels will result in improved knowledge and awareness of the epidemic among Canadians; strengthened community, public health and individual capacity to respond to the epidemic through efforts directed at prevention, and access to diagnosis, care, treatment and support; enhanced multi-sectoral engagement and alignment; and increased coherence of the federal response. | ||||
(in $ millions) | 7. Forecast Spending 2007-08 |
8. Planned Spending 2008-09 |
9. Planned Spending 2009-10 |
10. Planned Spending 2010-11 |
11. Program activity (PA): Infectious Disease Prevention and Control | ||||
12. Total grants | 6.7 | 6.6 | 6.6 | 6.6 |
12. Total contributions | 12.8 | 16.4 | 16.4 | 16.4 |
13. Total (PA) – Infectious Disease Prevention and Control | 19.5 | 23.0 | 23.0 | 23.0 |
14. Planned evaluations: Impact evaluation is planned for 2008-2009 | ||||
15. Planned audits: Audit plan is under development. |
1. Name of transfer payment program: National Collaborating Centres for Public Health (NCCPH) | ||||
2. Start date: 2004-2005 | 3. End date: Ongoing | |||
4. Description: Contribution to persons and agencies to support health promotion projects in the area of community health, resource development training and skill development and research. The National Collaborating Centres (NCCs) focus to develop, strengthen public health capacity and to transfer health knowledge to effectively prevent, manage and control infectious disease in Canada through joint collaboration at federal, provincial/territorial level but also with local governments, academia, public health practitioners and non-governmental organizations. | ||||
5. Strategic outcome: Healthier Canadians, reduced health disparities and a stronger public health capacity. | ||||
6. Expected results: The expected result of the National Collaborating Centres (NCCs) program include: (1) increased opportunities for collaboration with health portfolio and NCCs; (2) knowledge translation: exchange synthesis and application of scan and research findings disseminated among researchers and knowledge users; (3) knowledge gap identification: gaps are identified and act as catalysts for applied or new research; (4) networking: increased collaboration with NCCs occurs among and across public health at all levels; (5) increased availability of knowledge for evidence-based decision making in public health; (6) increased use of evidence to inform public health programs, policies and practices; (7) partnerships developed with external organizations; (8) mechanisms and processes in place to access knowledge; and (9) improved public health programs and policies. | ||||
(in $ millions) | 7. Forecast Spending 2007-08 |
8. Planned Spending 2008-09 |
9. Planned Spending 2009-10 |
10. Planned Spending 2010-11 |
11. Program activity (PA): Strengthen Public Health Capacity | ||||
12. Total contributions | 8.8 | 8.4 | 8.4 | 8.4 |
13. Total (PA) – Strengthen Public Health Capacity | 8.8 | 8.4 | 8.4 | 8.4 |
14. Planned evaluations: Under the Results-based Management and Accountability Framework (RMAF) with Risk Assessment (RA), a program evaluation on immediate outcomes are planned for 2008-2009 and will inform renewal of the terms and conditions. A summative evaluation is planned for 2011-2012. | ||||
15. Planned audits: No planned audits. |
1. Name of transfer payment program: Healthy Living Fund (national and regional streams) | ||||
2. Start date: October 2005 | 3. End date: Ongoing | |||
4. Description: Contribution funding to support and engage the voluntary sector and to build partnerships and collaborative action between governments, non-governmental organizations and other agencies. It supports healthy living actions with community, regional, national and international impact. | ||||
5. Strategic outcome: Healthier Canadians, reduced health disparities and a stronger public health capacity. | ||||
6. Expected results: Funding through the Healthy Living Fund will build public health capacity and develop supportive environments for physical activity and healthy eating. Projects will help to strengthen the evidence-base and contribute to the knowledge development and exchange component of the Strategy and will inform health promotion activities. | ||||
(in $ millions) | 7. Forecast Spending 2007-08 |
8. Planned Spending 2008-09 |
9. Planned Spending 2009-10 |
10. Planned Spending 2010-11 |
11. Program activity (PA): Health Promotion | ||||
12. Total contributions | 5.1 | 5.2 | 5.2 | 5.2 |
13. Total (PA) – Health Promotion | 5.1 | 5.2 | 5.2 | 5.2 |
14. Planned evaluations: The Healthy Living Fund (national and regional streams) will be using the Project Evaluation and Reporting Tool (PERT) to monitor and document the effectiveÂness of all contribution stakeholder projects, and to assess the impact these community-based programs are making on the health of Canadians and Canadian communities.
PERT is an evaluation tool that measures common indicators and provides a consistent approach to program measurement and data collection, as well as other formats as appropriate. In order to provide realistic and accurate portraits of the outcomes of and value created by participating programs, PERT is a common analysis framework from which questions relevant to all community-based programs have been developed. In addition, individual program questions will be developed specific to Healthy Living Fund outcomes. The information gathered will be used to measure and assess the implementation, impact, and effectiveness of the Healthy Living Fund. Program level results and lessons learned will be shared with the projects, their partners, with researchers, and within the Agency. The Healthy Living Fund falls within the federal Healthy Living and Chronic Disease Initiative. The Results-based Management and Accountability Framework (RMAF) for the ISHLCD commits to reviewing the implementation of the Integrated Strategy on Healthy Living and Chronic Disease. The First Implementation Review (inclusive of the Healthy Living Component), completed in December 2006, focused on the progress of implementing the coordination structures of the Integrated Strategy from October 2005 through November 2006. The Second Implementation Review, to be completed by March 2008, will examine the period from December 2006 through December 2007. Further evaluation of the Healthy Living Program Component, through to March 2009, will focus on progress towards achieving the immediate outcomes, and early progress towards intermediate outcomes. |
||||
15. Planned audits: A performance audit of this Program is scheduled in 2008-2009. Any audit of Recipients is done at the Program level. |
1. Name of transfer payment program: Canadian Diabetes Strategy (non-Aboriginal elements) | ||||
2. Start date: 2005-2006 | 3. End date: Ongoing | |||
4. Description: The Agency provides the leadership on the non-Aboriginal elements of the Canadian Diabetes Strategy, which has been in effect since 1999. Under the Agency’s Healthy Living and Chronic Disease Initiative, the renewed Canadian Diabetes Strategy will undergo a change of direction, targeting Canadians who are at higher risk, especially those who are overweight, obese or pre-diabetic (i.e. family history, high blood pressure, high cholesterol) and supporting approaches for the early detection and management of complications for type 1 and type 2 diabetes. | ||||
5. Strategic outcome: Healthier Canadians, reduced health disparities and a stronger public health capacity. | ||||
6. Expected results: Improved capacity to apply best practices and clinical practices guidelines to better, screen, educate and counsel Healthier public policies in organizations across sectors and jurisdictions addressing high risk populations, early detection and management of diabetes Increased organizational capacity for policy, program, services and research development Increased awareness and improved attitudes of high risk populations Increased knowledge among high-risk populations of skills and behaviours necessary to prevent diabetes and its complications |
||||
(in $ millions) | 7. Forecast Spending 2007-08 |
8. Planned Spending 2008-09 |
9. Planned Spending 2009-10 |
10. Planned Spending 2010-11 |
11. Program activity (PA): Chronic Disease Prevention and Control | ||||
12. Total grants | 3.5 | 3.5 | 3.5 | 3.5 |
12. Total contributions | 3.2 | 3.5 | 3.5 | 3.5 |
13. Total (PA) – Chronic Disease Prevention and Control | 6.7 | 7.0 | 7.0 | 7.0 |
14. Planned evaluations: Evaluation of the CDS will take place within the broader evaluation of the Healthy Living and Chronic Disease initiative, specifically:
|
||||
15. Planned audits: A performance audit of this Program is scheduled in 2009-2010. Any audit of Recipients is done at the Program level. |
1. Name of transfer payment program: Cancer | ||||
2. Start date: 2005-2006 | 3. End date: Ongoing | |||
4. Description: In 2005, the federal budget committed $300 million over five years and $74.5 million annually for the Integrated Strategy on Healthy Living and Chronic Disease (HLCD). This significant initiative is the first long-term, ongoing federal commitment to chronic disease. In addition to common platforms, cancer is one of three disease-specific
components of the HLCD. As a result, the Agency receives targeted funding from the Strategy for cancer work, such as community-based programming and capacity building. Furthermore, the Agency provides support as appropriate to the Canadian Partnership Against Cancer (CPAC), announced by the federal government in November 2006 to implement the Canadian Strategy on Cancer Control (CSCC). Specifically, the Agency supports links between CPAC’s knowledge translation activities and other cancer portfolio members, and promotes international activities and federal leadership on cancer. The CSCC’s strategic priorities (primary prevention; screening/early detection, standards, clinical practice guidelines; rebalancing the focus; health human resources; research; and surveillance and analysis) provide the overarching framework for cancer control in Canada. |
||||
5. Strategic outcome: Healthier Canadians, reduced health disparities and a stronger public health capacity. | ||||
6. Expected results: Under the HLCD, the Agency has six major components projected for 2007-2008/2008-2009. These include cancer community-based programming and capacity building through a grants and contributions program targeted at Aboriginals organizations, NGOs, seniors, immigrants and children; cancer surveillance activities largely focused on
children; cancer screening and early detection programs for colorectal cancer (working in partnership with CPAC); cancer risk factor analysis and assessment; monitoring and evaluation as required; and public information activities such as consultations and public opinion research. In addition, the Agency will work with CPAC, other stakeholders, and provincial/territorial representatives to develop a national cancer surveillance system. However, the Treasury Board Authorities for the funding and implementation of the CSCC through CPAC provide that the Agency’s cancer activities under the HLCD will not overlap with or duplicate the efforts of CPAC. As such, the Agency will focus its cancer community-based programming on the federal government’s health priorities of seniors, children, Aboriginals and the environment. Through ongoing consultations with various stakeholders, this will build capacity and facilitate the participation of these groups in the CSCC. |
||||
(in $ millions) | 7. Forecast Spending 2007-08 |
8. Planned Spending 2008-09 |
9. Planned Spending 2009-10 |
10. Planned Spending 2010-11 |
11. Program activity (PA): Chronic Disease Prevention and Control | ||||
12. Total grants | 2.9 | 3.2 | 3.2 | 3.2 |
12. Total contributions | 1.1 | 2.5 | 2.5 | 2.5 |
13. Total (PA) – Chronic Disease Prevention and Control | 4.0 | 5.7 | 5.7 | 5.7 |
14. Planned evaluations: An evaluation plan is currently being developed. The monitoring and evaluation plan for each component of the transfer program is based on the RMAF and Risk Assessment. Ongoing monitoring will be focused on key performance information (i.e. reach to targeted population), and an implementation review will examine progress during
the first few years of the program. The functional component evaluation (2008-2009) will focus on progress towards individual and societal level outcomes (i.e. relevance, cost effectiveness, results) and an outcome evaluation (2011-2012) will provide a summary of evaluative information for the programs. According to Treasury Board guidelines, 5% of all HLCD program resources must be for monitoring and evaluation. |
||||
15. Planned audits: A performance audit of this Program is scheduled in 2009-2010. Any audit of Recipients is done at the Program level. |
1. Name of transfer payment program: Canadian HIV Vaccine Initiative | ||||
2. Start date: 2007-2008 | 3. End date: 2012-2013 | |||
4. Description: The Canadian HIV Vaccine Initiative (CHVI) is a collaborative undertaking between the Government of Canada and the Bill & Melinda Gates Foundation to contribute to the global effort to develop a safe, effective, affordable and globally accessible HIV vaccine. This collaboration builds on the Government of Canada’s commitment to a comprehensive, long-term approach to address prevention technologies. Participating federal departments and agencies are the Public Health Agency of Canada, Industry Canada, Health Canada, the Canadian Institutes of Health Research, and the Canadian International Development Agency. The CHVI’s overall objectives are to: strengthen HIV vaccine discovery and social research capacity; strengthen clinical trial capacity and networks, particularly in low and middle income countries (LMICs); increase pilot scale manufacturing capacity for HIV vaccine clinical trial lots; strengthen policy and regulatory approaches for HIV vaccines and promote the community and social aspects of HIV vaccine research and delivery; and ensure horizontal collaboration within the CHVI and with domestic and international stakeholders. | ||||
5. Strategic outcome: Healthier Canadians, reduced health disparities and a stronger public health capacity. | ||||
6. Expected results:
|
||||
(in $ millions) | 7. Forecast Spending 2007-08 |
8. Planned Spending 2008-09 |
9. Planned Spending 2009-10 |
10. Planned Spending 2010-11 |
11. Program activity (PA): Infectious Disease Prevention and Control | ||||
12. Total contributions | 0.0 | 0.8 | 9.3 | 9.5 |
13. Total (PA) – Infectious Disease Prevention and Control | 0.0 | 0.8 | 9.3 | 9.5 |
14. Planned evaluations: Mid-term evaluation is planned for 2009-2010 and Summative evaluation for 2012. | ||||
15. Planned audits: No planned audits. |
1. Name of transfer payment program: Hepatitis C Undertaking | ||||
2. Start date: April 2000 | 3. End date: March 31, 2019 | |||
4. Description: Payments to Provinces and Territories to improve access to health care and treatment services to persons infected with Hepatitis C through the blood system. | ||||
5. Strategic outcome: Healthier Canadians, reduced health disparities and a stronger public health capacity. | ||||
6. Expected results: Improved access to current emerging antiviral drug therapies, other relevant drug therapies, immunization and health care services for the treatment of Hepatitis C infection and related medical conditions. | ||||
(in $ millions) | 7. Forecast Spending 2007-08 |
8. Planned Spending 2008-09 |
9. Planned Spending 2009-10 |
10. Planned Spending 2010-11 |
11. Program activity (PA): Infectious Disease Prevention and Control | ||||
12. Total other types of transfer payments | 0.0 | 0.0 | 49.7 | 0.0 |
13. Total (PA) – Infectious Disease Prevention and Control | 0.0 | 0.0 | 49.7 | 0.0 |
14. Planned evaluations: An evaluation was completed in 2006-2007. The next evaluation is scheduled for 2010-2011. | ||||
15. Planned audits: No planned audits. |
The following table provides a list of the proposed evaluation-related projects that were received in response to a call for evaluation plans from the Centre for Excellence in Evaluation and Program Design (CEEPD).
Name of Policy, Program, or Initiative | Due Date |
Canada Prenatal Nutrition Program | 2008-2009 |
Cells, Tissues and Organ Surveillance System | 2008-2009 |
Community Action Program for Children | 2008-2009 |
Federal Initiative on HIV/AIDS (comprehensive evaluation) | 2008-2009 |
Fetal Alcohol Spectrum Disorder | 2008-2009 |
Integrated Strategy on Healthy Living and Chronic Disease (component evaluation) | 2008-2009 |
National Collaborating Centres for Public Health | 2008-2009 |
Population Health Fund | 2008-2009 |
Transfusion Transmitted Injuries Surveillance System | 2008-2009 |
Hepatitis C Prevention, Support and Research Program | 2009-2010 |
National Immunization Strategy | 2009-2010 |
Pandemic Influenza Preparedness: Mock Vaccine Development | 2009-2010 |
Public Security and Anti-Terrorism | 2009-2010 |
Scholarship and Bursaries Program | 2009-2010 |
Integrated Strategy on Healthy Living and Chronic Disease (synthesis review) | 2010-2011 |
Canada Health Infoway Inc. (Infoway) is an independent not-for-profit corporation with a mandate to foster and accelerate the development and adoption of electronic health information systems with compatible standards and communications technologies across Canada. Infoway is also a collaborative mechanism in which the federal, provincial and territorial governments participate as equals, toward a common goal of modernizing Canada’s health information systems. See Health Canada’s RPP for the reporting on this Foundation Initiative.
1. | How is your department planning to meet the objectives of the Policy on Green Procurement? | |
The Agency has set Objective 2.1 in its SDS: Maximize use of green procurement. | ||
2. | Has your department established green procurement targets? | |
Yes | ||
3. | Describe the green procurement targets that have been set by your department and indicate the associated benefits anticipated. | |
Target 2.1.1 | Provide procurement training to 75% of material managers and integrate green procurement into training for acquisition cards by December 31, 2008 | Increase in volume of green goods/commodities purchased |
Target 2.1.2 | Meet the Government of Canada standards for purchase and by March 31, 2010, meet the guidelines for operations of office equipment | Energy savings, green recycling process for disposed equipment, use of more environmentally friendly equipment |
Target 2.1.3 | Establish a baseline of the Agency’s green procurement patterns and, by December 31, 2008, explore options to develop an effective, efficient and affordable green tracking system | Baseline of the Agency’s green procurement patterns established and options for tracking options identified |
Target 2.1.4 | Increase awareness of “green travel” options to 50% of all the Agency employees by March 31, 2009 | Increased awareness of green travel options will lead to use of green travel options, including use of alternative modes of transportation |
Over the next three years, the Public Health Agency of Canada will participate in the following horizontal initiatives:
Name of Horizontal Initiative: Canadian HIV Vaccine Initiative | |||||
Name of Lead Department(s): Public Health Agency of Canada |
Lead Department Program Activity: Infectious Disease Prevention and Control |
||||
Start Date of the Horizontal Initiative: February 20, 2007 |
End Date of the Horizontal Initiative: March 2013 |
||||
Total Federal Funding Allocated (start to end date): $111M | |||||
Description of the Horizontal Initiative (including funding agreement): The Canadian HIV Vaccine Initiative (CHVI), Canada’s contribution to the Global HIV Vaccine Enterprise, is a collaborative undertaking between the Government of Canada and the Bill and Melinda Gates Foundation to contribute to the global effort to develop a safe, effective, affordable and globally accessible HIV vaccine. This collaboration builds on the Government of Canada’s commitment to a comprehensive, long-term approach to address prevention technologies. Participating federal departments and agencies are the Public Health Agency of Canada, Industry Canada, Health Canada, the Canadian Institutes of Health Research, and the Canadian International Development Agency. The CHVI’s overall objectives are to: strengthen HIV vaccine discovery and social research capacity; strengthen clinical trial capacity and networks, particularly in low and middle income countries (LMICs); increase pilot scale manufacturing capacity for HIV vaccine clinical trial lots; strengthen policy and regulatory approaches for HIV vaccines and promote the community and social aspects of HIV vaccine research and delivery; and ensure horizontal collaboration within the CHVI and with domestic and international stakeholders. |
|||||
Shared Outcome(s): Immediate (Short-Term 1 - 3 years) Outcomes: • Increased and improved collaboration and networking • Enhanced knowledge base • Increased readiness and capacity in Canada and LMICs Intermediate Outcomes: • Pilot Scale vaccines clinical trial lot manufacturing is fully operational and globally accessible • Strengthened contribution to global efforts to accelerate the development of safe effective, affordable, and globally accessible HIV vaccines Long -Term Outcomes: • The Canadian HIV Vaccine Initiative contributes to the global efforts to reduce the spread of HIV/AIDS particularly in LMICs. |
|||||
Governance Structure(s): The Minister of Health, in consultation with the Minister of Industry and of International Cooperation, will be the lead Minister for the CHVI for the purposes of overall coordination. Communications for the CHVI will be handled jointly. In support of the Ministers, coordination for the Government of Canada will be provided by an Interdepartmental Steering Committee consisting of representatives from the participating federal departments and agencies. The Interdepartmental Steering Committee will be responsible for providing strategic directions and priorities and reviewing progress. Multi-stakeholder advisory committees and working groups, involving governments, the private sector, international stakeholders, people living with HIV/AIDS, researchers and NGOs and other relevant stakeholders, will be established to inform the CHVI. The role of participating departments and agencies involved in the CHVI are: The Public Health Agency of Canada (http://www.phac-aspc.gc.ca/new_e.html) contributes its public health scientific, policy and program expertise and provides secretariat support for the CHVI. Health Canada (http://www.hc-sc.gc.ca/english/index.html) applies its wider range of expertise, including vaccine related policy, regulations and protocols; facilitate collaborative networks of specialists with a particular focus on the community and social dimensions of vaccine research, development and delivery; and enhance international collaborations. Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) provides scientific leadership and strategic guidance through its linkages to the Canadian research community, as well as brings critical expertise in peer review mechanisms and related professional support services to identify and fund eligible HIV vaccines projects. Industry Canada (http://www.ic.gc.ca/ic_wp-pa.html) applies its industry specific knowledge and experience to provide linkages to the Canadian and International vaccine industry, as well as assist with industry-related issues, including the appropriate engagement of potential private sector collaborators. Canadian International Development Agency (http://www.acdi-cida.gc.ca/cidaweb/acdicida.nsf/En/Home ) provides effective linkages to international development efforts and ensures consistency with Canada’s international commitments. Moreover, CIDA will provide strategic guidance to ensure that the goals of the CHVI promote the development and delivery of HIV vaccines that benefit the needs of the highly endemic HIV/AIDS countries in the developing world. |
|||||
Federal Partners | Federal Partner Program Activity (PA) | Names of Programs for Federal Partners | Total Allocation from (start to end date) | Planned Spending for 2008-2009 | Expected Results for 2008-2009 |
1. PHAC | PA: Infectious Disease Prevention and Control | Public Health Contributions Program | $27M | $2.16M | Completed open and transparent selection process for a Not for Profit Corporation to build and operate a pilot scale clinical trial lot manufacturing facility 1st joint (Canada-international partner-led) policy dialogue completed New HIV Vaccine Community Engagement Funding Program implemented (in partnership with Health Canada) Secretariat support services provided to CHVI committees Evaluation framework design completed CHVI website and day-to-day communications managed |
2. HC | Program Activity 1.3 International Health Affairs | Grants to eligible non-profit international organizations in support of their projects or programs on health | $1M | $0.2M | New HIV Vaccine Community Engagement Funding Program implemented (in partnership with the Agency) |
3. IC | Strategic outcome: innovative economy Program Activity: Industry Sector- Science and Technology and Innovation |
N/A | $13M | $3.25M | Support provided to (Agency-led) open and transparent selection for pilot scale manufacturing facility for HIV vaccines clinical trial lots |
4. CIDA | Program Activity 1.4, Institutions -- Enhanced capacity and effectiveness of Multilateral institutions and Canadian/ International organizations in achieving development goals | International Development Assistance Program | $60M | $8.85M | In collaboration with CIHR, establishment of a large team discovery and social research program to foster and support larger, collaborative teams of Canadian and LMICs researchers Establishment of a program to support teams of Canadian and LMICs researchers and research institutions to strengthen their capacity to conduct high-quality clinical trials of HIV vaccine and other related prevention technologies Activities supported to improve regulatory capacity in LM ICs, especially those where clinical trials are planned or ongoing Support provided to (Agency-led) open and transparent selection for pilot scale manufacturing facility for HIV vaccines clinical trial lots |
5. CIHR | HIV/AIDS Research Initiative -- Program Activity Architecture Code: 12300 | HIV/AIDS Research Initiative | $10M | $2M | Canadian researchers, working either independently or in small teams, supported through operating grant programs In collaboration with CIDA, establishment of a large team discovery and social research program to foster and support larger, collaborative teams of Canadian and LMICs researchers |
Total | $111.0M | $16.46M | |||
Results to be achieved by Non-Federal Partners): Non-governmental stakeholders (including research institutions and not-for-profit community organizations) are integral to the success of the CHVI. Their role is to engage and collaborate with participating departments and agencies, the Bill and Melinda Gates Foundation and other funders to contribute to CHVI objectives and to a significant Canadian contribution towards the Global HIV Vaccine Enterprise. |
Contact Information: Steven Sternthal Tel: 613-952-5120 |
Name of Horizontal Initiative: The Federal Initiative to Address HIV/AIDS in Canada http://www.phac-aspc.gc.ca/aids-sida/hiv_aids/index.html | ||||
Name of Lead Department(s): Public Health Agency of Canada |
Lead Department Program Activity: Infectious Disease Prevention and Control |
|||
Start Date: January 13, 2005 | End Date: Ongoing | |||
Total Federal Funding Allocated: • 2005/06 - $55.2M • 2006/07 - $63.2M • 2007/08 - $71.2M • 2008/09 - $84.4M (ongoing) |
||||
Description: The Federal Initiative to Address HIV/AIDS in Canada is the Government of Canada's response to HIV/AIDS in Canada. The initiative will strengthen domestic action on HIV/AIDS, build a coordinated Government of Canada approach, and support global health responses to HIV/AIDS. It will focus on prevention and access to diagnosis, care, treatment and support for those populations most affected by the HIV/AIDS epidemic in Canada - people living with HIV/AIDS, gay men, Aboriginal people, people who use injection drugs, inmates, youth, women, and people from countries where HIV is endemic. The Federal Initiative will also support and strengthen existing multi-sectoral partnerships to address the determinants of health. It will support collaborative efforts to address factors which can increase the transmission and acquisition of HIV including sexually transmitted infections (STI) and also address co-infection issues with other infectious diseases (for example, hepatitis C and tuberculosis) from the perspective of disease progression and morbidity in people living with HIV/AIDS. Gender-based analysis and human rights analysis are fundamental to the approach. People living with and vulnerable to HIV/AIDS will be active partners in shaping policies and practices affecting their lives. |
||||
Shared Outcomes: Immediate (Short-Term 1 - 3 years) Outcomes: • Increased and improved collaboration and networking; • Increased availability and use of evidence; • Improved quality assurance in HIV testing; • Increased coherence of federal response; • Increased awareness of HIV/AIDS; • Improved attitudes and behaviours towards people living with HIV/AIDS; and • Increased capacity (knowledge and skills) of individuals and organizations; Intermediate Outcomes: • Increased practice of healthy behaviours • Improved access to quality HIV/AIDS prevention, diagnosis, care treatment and support; and • Strengthened pan-Canadian response to HIV/AIDS. Long-Term Outcomes: Federal Initiative to Address HIV/AIDS in Canada contributes to the: • Improved health status of persons living with or vulnerable to HIV; • Reduction of social and economic costs of HIV/AIDS to Canadians; and • Global effort to reduce the spread of HIV/AIDS and mitigate its impact. |
||||
Governance Structures: The Public Health Agency of Canada (http://www.phac-aspc.gc.ca/new_e.html) is the federal lead for issues related to HIV/AIDS in Canada. The Public Health Agency is responsible for overall coordination, communications, national/regional programs, policy development, surveillance and laboratory science. Health Canada (http://www.hc-sc.gc.ca/english/index.html) supports community-based HIV/AIDS education, capacity-building, and prevention for First Nations on-reserve and Inuit communities; provides leadership on international health policy and program issues; and assistance and guidance on evaluation. As the Government of Canada's agency for health research, the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) sets priorities for and administers the extramural research program. Correctional Service Canada, (http://www.csc-scc.gc.ca/text/home_e.shtml) which is an agency of the Ministry of Public Safety and Emergency Preparedness Canada (http://www.psepc.gc.ca/abt/index-en.asp), provides health services, including services related to the prevention, diagnosis, care and treatment of HIV/AIDS, to offenders sentenced to imprisonment for two years or more. An interdepartmental coordinating committee has been established by the Public Health Agency to promote policy and program coherence among the participating departments and agencies, and to maximize the use of available resources. Health Canada's International Affairs Directorate coordinates global engagement activities and provides the secretariat for the Consultative Group on Global HIV/AIDS Issues. The Consultative Group on Global HIV/AIDS Issues acts as a forum for dialogue between government and civil society on Canada's response to the global pandemic, and includes the provision of advice; guidance and suggestions regarding collaboration and policy coherence to ensure a more effective response. The Interdepartmental Forum on Global HIV/AIDS Issues meets quarterly to discuss on-going issues and to provide overall coordination and coherence in the federal government's approach to the global pandemic. Participating departments and agencies include the Agency, Health Canada, CIDA, DFAIT, and the Canadian Institutes of Health Research. Other government departments are invited to attend on an as-needed basis. The Ministerial Council on HIV/AIDS (http://www.phac-aspc.gc.ca/aids-sida/fi-if/minister_e.html) provides independent advice to the Minister of Health on pan-Canadian aspects of HIV/AIDS. The Federal/ Provincial/ Territorial Advisory Committee on AIDS (http://www.phac-aspc.gc.ca/aids-sida/fi-if/ftp_e.html) serves as a forum to promote a coordinated governmental response to the HIV/AIDS epidemic. The National Aboriginal Council on HIV/AIDS (http://www.phac-aspc.gc.ca/aids-sida/fi-if/national_e.html) provides advice to the Public Health Agency of Canada and Health Canada on issues relating to HIV/AIDS and Aboriginal populations. The Federal/Provincial/Territorial (FPT) Heads of Corrections Working Group on Health is a sub-committee of the FPT Heads of Corrections. The Working Group on Health promotes policy and program development that is informed and sensitive to the complex issues surrounding the health of inmates, and provides advice to the FPT Heads of Corrections on trends and best practices as they relate to health in a correctional setting. Other federal departments have mandates to address broader social determinants that affect people living with HIV/AIDS or their vulnerability to acquiring the infection, as well as to address the global epidemic. A Government of Canada Assistant Deputy Ministers' Committee on HIV/AIDS has been struck to establish appropriate links and assist with the development of a broader Government of Canada approach to HIV/AIDS. |
||||
Federal Partners Involved in each program | Names of Programs / Program Activity |
Total Allocation | Planned Spending for 2008-09 (Millions) |
Expected Results for 2008-09 |
Public Health Agency of Canada | Infectious Disease Prevention and Control / Infectious Disease Prevention and Control | $35.2 M (plus $0.1 from HC-DPMED) |
$27.6 M (plus $0.1 from HC-DPMED) |
Increased awareness of HIV/AIDS epidemic in Canada and the factors that contribute to its spread through: - development of an Agency-led social marketing campaign and support for targeted campaigns in populations most at-risk Increased availability and use of evidence through: - augmented risk behaviour surveillance; and - targeted epidemiologic studies (expansion of I-TRACK and M-TRACK) and development of programs in other at-risk populations (A-track for Aboriginal populations); - improved knowledge and characterization of the transmission of drug-resistant HIV in Canada; and - improved reporting on progress through the implementation of the Federal Initiative's performance management framework Improved quality assurance in HIV testing through: - maintenance and improved quality of HIV testing in Canada; - enhanced ability to monitor the performance of testing kits and algorithms used in provincial public laboratories; and - enhanced HIV reference services Strengthened pan-Canadian response to HIV/AIDS through: - the development of a population specific framework for the Federal Initiative, and status reports for gay men, women, people from countries where HIV/AIDS is endemic, Aboriginal people, people who use injection drugs, youth at risk, prison inmates and people living with HIV/AIDS; and - the development of a national HIV/AIDS research planning and knowledge exchange framework to strengthen the availability and utilization of evidence to inform policies and programs Increased and improved collaboration and networking through: - the review and re-design of committees and advisory bodies Improved access to quality prevention, diagnosis, care, treatment and support through: - increased availability of evidence-based HIV interventions which address the determinants of health; and - increased availability of evidence-based HIV interventions which address co-infections which increase the susceptibility to acquiring and transmitting HIV (eg. other sexually transmitted infections [STIs]) and other infectious diseases which increase disease progression and morbidity in people living with HIV/AIDS (eg. hepatitis C, STIs, tuberculosis) Increased capacity (knowledge and skills) of individuals and organizations through: - support for health and education professionals by providing evidence based guidelines, training and technical assistance on issues related to HIV/AIDS and other infectious diseases. - the implementation of a national HIV/AIDS knowledge broker to gather, synthesize and disseminate HIV/AIDS knowledge to strengthen the capacity of front-line organizations to develop and implement evidence-based programs and interventions - developing the capacity for monitoring and evaluation of the HIV/AIDS epidemic in Canada |
AIDS Community Action Program (ACAP)/Infectious Disease Prevention and Control | $16.7 M | $15.0 M | Increased and improved collaboration and networking through: - multi-sectoral partnership development Increased awareness of HIV/AIDS through: - funding projects to engage target populations in awareness raising (promotion and prevention) events, presentations and campaigns on HIV/AIDS - Supporting initiatives which explore and address issues of co-infection with Hepatitis C, TB and STIs Increased capacity (knowledge and skills) of individuals and organizations through: - funding projects to provide skills building sessions for staff and volunteers. - development of specific strategies to reach priority populations, i.e. injection drug users, gay men, Aboriginal people, youth at risk, prison inmates, women, people from countries where HIV/AIDS is endemic Improved attitudes and behaviours towards people living with HIV/AIDS through: - policy changes and other initiatives that create a more supportive environment for people living with HIV/AIDS Improved access to quality HI/AIDS prevention, diagnosis, care, treatment and support through: - funding projects to increase the awareness of the social and economic factors that create barriers for those at risk and those people living with HIV/AIDS (e.g. addictions, housing, income) |
|
Health Canada (HC) | First Nations On-Reserve First Nations Inuit Health Programming and Services |
$4.0 M | $5.3 M | Increased awareness of HIV/AIDS: improved attitudes and behaviours through: -Support to regions and communities in their efforts to launch HIV/AIDS community awareness campaigns that challenge negative attitudes and behaviours -Support to Aboriginal organizations (AFN, CAAN, Pauktuutit) on HIV/AIDS activities with particular focus on youth, leaders and women Improved coherence of federal response through: -ongoing development of relationships within FNIHB, the Agency, and with other FN/I partners such as INAC and Correctional Services to increase interdepartmental collaboration Increased availability and use of evidence through: -Development of recommendations on how to expand HIV/AIDS program to other blood-borne pathogens (Hepatitis C and Sexually transmitted infections) -Promotion of efforts for the collection of epidemiological and surveillance data to enhance understanding progression of HIV/AIDs and HCV and increase the relevancy and effectiveness of the program |
Global Engagement Program Activity 1.3 International Health Affairs |
$1.7 M | $1.6 M | Improved coherence of the federal response through: - coordinated Government of Canada engagement in the XVII International AIDS Conference - expanded information sharing opportunities and collaborative activities with international organizations and within international fora - increased policy coherence across the Federal Government's global HIV/AIDS activities Strengthened pan-Canadian response to HIV/AIDS through: - support for projects that engage Canadian organizations in the global response to HIV/AIDS |
|
Program Evaluation (Transferred to the Agency – Infectious Disease Prevention and Control/ Infectious Disease Prevention and Control |
Improved coherence of Federal response through : - the provision of strategic performance management framework: ongoing performance measurement, monitoring, evaluation and reporting of performance results Increased capacity (knowledge and skills) of individuals and organizations through: - developing the capacity for monitoring and evaluation of the HIV/AIDS epidemic in Canada |
|||
Canadian Institutes of Health Research (CIHR) | HIV/AIDS Research Projects and Personnel Support/ HIV/AIDS Research Initiative | $22.6 M | $20.6 M | Increased and improved collaboration and networking through: - funding of and participating in HIV/AIDS conferences/workshops; and - participating in FI Accountability Working Group and Responsibility Center Committee and engaging appropriate federal partners in CIHR activities Increased availability and use of evidence through: - funding HIV/AIDS research projects across a broad spectrum including socio-behavioural, biomedical, clinical, clinical trials infrastructure, and community-based research; and - providing new research funding opportunities for scientists in strategic areas of HIV/AIDS research Increased capacity (knowledge and skills) of individuals and organizations through: - launching strategic capacity building initiatives and providing funding for training and salary awards Strengthened pan-Canadian response to HIV/AIDS through: - finalizing a strategic plan for the CIHR HIV/AIDS Research Initiative and communicating it broadly; - participating in the development of a national research and knowledge translation framework; and - building effective partnerships with and engaging in meaningful dialogue with key stakeholders |
Correctional Service Canada (CSC) | Health Services Program activity: 1.0 Custody (Garde) under public health services in institutions; Program Sub-activity 1.3 Institutional Health Services; Program sub-sub activity 1.3.1 Public Health Services And Program activity 3.0 Community Supervision for public health services for offenders under supervision in the community. Program sub-activity: 3.3 Community Health Services Program sub-sub activity: 3.3.1 Community Public Health Services |
$4.2 M | $4.2 M | Improved collaboration and networking through: - expanded information sharing opportunities and collaborative activities within the F/P/T/ Heads of Corrections Working Group Increased awareness of HIV/AIDS through: - increased awareness of the need for innovative research initiatives on infections diseases within the federal offender population Increased capacity (knowledge and skills) of individuals and organizations through: - continued support of and participation in training and learning opportunities for correctional health care professionals Improved access to quality prevention, diagnosis, care, treatment and support through: - improved coordinated discharge planning programs for federal offenders with infectious diseases and other physical health problems being released into the community - enhanced, gender specific infectious disease care, treatment and support, in accordance with professionally accepted health standards for women offenders through the development of a framework for a women offender infectious disease strategy - culturally appropriate health programs and services for Aboriginal offenders in federal correctional institutions; - reduced transmission of infectious diseases among federal offender populations through sustained harm reduction programs and measures; and - expanded health promotion initiatives to encourage healthy behaviours with the federal correctional environment Increased availability and use of evidence through: - augmented surveillance and data collection activities in order to better inform infectious diseases policy and program initiatives; and - better informed internal policies and programs using results of an extensive inmate survey on risk behaviours |
Total | $84.4 M in 2008-09 | $74.3 M | - 2008-09 total planned spending includes $1.3M additional investment by HC-FNIHB | |
Results to be achieved by Non-Federal Partners: Major non-governmental stakeholders are considered full partners in the Federal Initiative to Address HIV/AIDS in Canada. Their role is to engage and collaborate with all levels of government, communities, other non-governmental organizations, professional groups, institutions and the private sector to enhance the Federal Initiative to Address HIV/AIDS in Canada's progress on all outcomes identified above. |
||||
Contact: Marsha Hay Snyder Tel. 613-946-3565 Marsha_Hay-Snyder@phac-aspc.gc.ca |
Approved by: Felix Li Tel. 613-948-3557 Felix_li@phac-aspc.gc.ca |
November 2007 |
Name of Horizontal Initiative: Preparedness for Avian and Pandemic Influenza | ||||
Name of Lead Department(s): Public Health Agency of Canada | Lead Department Program Activity: Infectious Disease Prevention and Control | |||
Start Date of the Horizontal Initiative: late 2006 | End Date of the Horizontal Initiative: ongoing | |||
Total Federal Funding Allocation (start to end date): $617M from 2006-2007 to 2010-2011 | ||||
Description of Horizontal Initiative (including funding agreement): Canada is facing 2 major, inter-related animal and public health threats: the potential spread of avian influenza virus (H5N1) to wild birds and domestic fowl in Canada and the potential for a human-adapted strain to arise, resulting in human-to-human transmission,
potentially triggering a human influenza pandemic. A coordinated and comprehensive plan to address both avian and pandemic influenza is required. In 2006 the Health Portfolio received $422M over 5 years to improve preparedness for avian and pandemic influenza. The bulk of the initiatives are ongoing. Initiatives are being launched in the areas of vaccines and antivirals, surge capacity, prevention and early warning, emergency preparedness, critical science and regulation, risk communication, and inter-jurisdictional collaboration. Efforts also will be undertaken to fill gaps in on-reserve planning and preparedness and enhance federal capacity to deal with an on-reserve pandemic. Under the umbrella of “Preparing for Emergencies”, in 2006 the CFIA obtained $195M to be spent over 5 years to enhance Canada’s state of AI preparedness. Canada’s Avian Influenza Working Group was established in 2006 to update policies, protocols, operating procedures, and systems to enhance Canada’s state of preparedness—through collaborations and partnership— in 5 pillars of strategies and processes for prevention and early warning, emergency preparedness, emergency response, recovery, and communications. |
||||
Shared Outcome(s): These initiatives will allow the federal government to strengthen Canada’s capacity to prevent and respond to immediate animal health and economic impacts of avian influenza while increasing preparedness for a potential pandemic. Greater Protection for Canadians will come about with improved vaccines and antivirals, improved emergency preparedness, and increased surge capacity to better address peak periods, as well as through critical science and regulation processes in the area. There will be enhanced on-reserve planning and preparedness and improved federal capacity to deal with an on-reserve pandemic. Response Speed and Understanding will be enhanced through prevention and early warning measures, risk communication and inter-jurisdictional collaboration. |
||||
Governance Structure(s): The governance structure is in its final stages of development. Under the auspices of the Deputy Minister’s Committee on Avian and Pandemic Influenza Planning (CAPIP) a series of committees and working groups will be established focussing on each of the key horizontal areas coordinated by a DG committee with leadership provided by an ADM committee with a representative from each of the funded departments or agencies. This structure will be in place before the end of the fiscal year 2007-08. | ||||
Federal Partners | Names of Programs for Federal Partners | Total Allocation (from start to end date) | Planned Spending for 2008-2009 |
Expected Results for 2008-2009 |
1.PHAC | a. Vaccine readiness & clinical trials | ongoing | $ 13.3M | Support for expanded production capacity and production of clinical trials of a mock H5N1 vaccine will help ensure timely availability of a safe and effective vaccine to all Canadians in the event of a pandemic, helping to reduce the extent of illness and death. Improved vaccine adverse event reporting for both annual flu vaccine campaigns and the use of a vaccine in a pandemic will allow a timely response to any adverse effects and increase public confidence in Canada’s public health system. |
b. Rapid vaccine development and testing | ongoing | $1.8M | Enhanced domestic ability for research and development of vaccines for novel influenza viruses and other emerging infectious diseases and an improved body of knowledge will contribute to the development of new strategies for influenza vaccines, which will help allow a more timely and effective response to future influenza threats. | |
c. Contribution to National Antiviral Stockpile | ongoing | $12.7M |
An increased national stockpile of antivirals for the use of health care professionals/institutions will allow treatment to all Canadians who need it, helping to bridge the gap until a pandemic vaccine can be produced and thereby reducing the number of deaths in the event of a pandemic. | |
d. Additional antivirals in NESS | $12.5M in 2007-08 only | $0M | An antiviral reserve beyond the national antiviral stockpile will give the Government of Canada the flexibility to support the initial containment of a potential pandemic influenza outbreak, either domestically or abroad, by providing surge capacity to support P/T efforts against an outbreak and by providing appropriate protection to designated essential federal employees. This will contribute to a more timely and effective response to a pandemic situation thus providing better protection of Canadians. | |
e. Capacity for Pandemic Preparedness | ongoing | $4.9M | Strengthened capacity for pandemic issues will allow the Agency to provide more strategic policy advice to the Minister and support improved collaboration and coordination on avian and human influenza issues across the Government, with provinces and territories, internationally, and with the private sector. Further, strengthened capacity for policy
advice in F/P/T liaison, the private sector and executive briefing will allow for more timely identification of issues and responsive decision making in a changing environment. In 2008-09, Agency Regional Offices will provide timely and consistent strategic regional intelligence on matters related to avian and pandemic influenza. A system to collect, analyze and disseminate regional intelligence will be developed which, along with more coordinated intergovernmental and regional communication involving the federal health portfolio and other stakeholders, will strengthen collaboration and increase the capacity of the Agency and its partners to anticipate and respond to an outbreak. |
|
f. Surveillance Program | ongoing | $8.9M |
Improved and interoperable components of the Canadian public health surveillance system will reach into a broader range of settings/issues such as surveillance in health care settings, wildbird surveillance and ensuring the safety of the blood supply. This system, supported by a robust systems platform, new and/or improved policies and/or information sharing agreements, and the efficient analysis and interpretation of the data collected, will allow more timely identification of potential outbreaks, thereby moving towards a more effective response and thus reducing illness and death in the event of an avian influenza outbreak or human influenza pandemic. | |
g. Emergency preparedness | ongoing | $7.1M | A more robust, efficient, effective response to a human influenza pandemic through improved communications, integrated and tested plans, and improved local capacity will result in reduced mortality and morbidity among Canadians, and demonstrate Government of Canada leadership and foresight in the event of an avian or pandemic influenza
outbreak. The Agency’s Regional Offices are actively engaged in promoting and enhancing national, regional and provincial/territorial pandemic planning through a variety of activities, including facilitating and promoting pandemic planning among federal departments and with provincial, Aboriginal and local governments and stakeholders. |
|
h. Emergency human resources | ongoing | $0.4M | A viable response plan for the HR capacity of the Agency and effective operational support to meet Agency requirements during a health crisis will allow the quick mobilization of Agency staff members in the event of a health crisis. Supporting preparedness measures will ensure that Agency’s services to Canadians can continue uninterrupted in the event of a public health emergency, reinforcing public confidence in the Canadian health system. | |
i. Winnipeg lab & space optimization | ongoing | $4.5M | Additional biocontainment research space will allow additional efforts on diagnostic testing and research on avian and human influenza, resulting in more timely identification of a pandemic virus and a better understanding of its characteristics, thus helping to reduce illness and death in the event of an outbreak or pandemic. Establishing an off-site storage and stores facility will allow the NML to reallocate existing lab-related space and expand the capacity to receive and process specimens. |
|
j. Strengthening the public health lab network | ongoing | $1.2M | An increased and better linked and coordinated capacity across jurisdictions for laboratory diagnostic testing, with a focus on antiviral, immunization and surveillance issues, will help to ensure the more timely identification of new or emerging viruses, allowing a pandemic virus to be more quickly isolated so that vaccines and more effective treatment options can be developed, thus reducing illness and death in the event of an avian influenza outbreak or human pandemic. | |
k. Influenza research network | ongoing | $6.8M | Improved decision-making respecting pandemic preparedness, control and treatment through systematic identification of research priorities along with mechanisms to rapidly generate research findings and promote access to and utilization of new knowledge through effective translation strategies. | |
l. Pandemic influenza risk assessment & modelling | ongoing | $0.8M | An improved federal capacity for mathematical modelling, statistical analysis, and operations research on pandemic influenza issues will allow a better understanding of the spread of influenza and the effect of epidemics or pandemics on Canadians, allowing more timely and evidence-based decision making on public health responses, thus helping to reduce the extent of illness or death in the event of an avian influenza outbreak or human pandemic. | |
m. Performance & evaluation | ongoing | $0.6M | Collection of relevant information to effectively measure the design, management, implementation, and impact of the Pandemic Influenza Strategy. Future evaluation activities and measurement of intended outcomes will contribute to ongoing decision making that reflects best practices and ensures value for money, thereby ensuring that avian and pandemic influenza preparedness measures are reaching their intended objectives. | |
n. Pandemic influenza risk communications Strategy | ongoing | $1.8M | Provide citizens, governments and key stakeholders with appropriate information to make effective decisions about health and safety before and during an influenza pandemic. Ensure consistent and complementary communications among health partners through strong communications networks. Support the federal government’s leadership role and credibility with citizens and partner organizations to reinforce confidence in Canada’s public health system, before, during, and after an influenza pandemic. |
|
o. Skilled national public health workforce | ongoing | $5.6M | The new Canadian Public Health Service Program (CPHSP) will hire a variety of public health professionals to address key gaps in P/T, local jurisdictions and other public health organizations, as part of an expanded and strengthened public health work force. Public Health Officers in this program are directly serving their host organizations, while
having the benefit of individualized learning plans supported by the Agency. Through the combination of career-positive professional development and field experience, the program will address current gaps in public health at all levels, including planning, surveillance and management of disease, risks to health, and emergency response with particular reference to avian
or pandemic influenza. In 2008-2009 discussions will be concluded with all provincial departments of health to determine public health capacity gaps and how CPHS staff can be most effectively deployed to address them. A system of regional coordination will contribute to efforts to achieve better integration across jurisdictions and address gaps and surge capacity. |
|
2.HC | a. Regulatory activities related to Pandemic Influenza Vaccine | ongoing | $1.4M | HPFB will implement the recommendations of the World Health Organization (WHO) assessment visit of National Regulatory Authority held in January 2007. The official report will be received in late 2007-08.[The unofficial report gave Canada a passing grade, and suggested minor revisions]. Health Canada is proceeding with amendments to the Food and Drug Regulations to introduce new regulations for Extraordinary Use New Drugs (e.g. an authorization process specific to drugs for emergency preparedness) and Block Special Access Programme (e.g. the release of a quantity of unauthorized drug for use in an emergency scenario). It is anticipated that these amendments will be finalized by early 2008-2009. Should a pandemic be declared in advance of completion of these amendments, they would be implemented via the interim order provision. Health Canada will be preparing an interim order to authorize a vaccine against H5N1 strain, which would then be donated to WHO for stockpiling and distribution to lesser developed countries in need of vaccine. This order will be drafted by end of this fiscal year. |
b. Resources for review and approval of antiviral drug submissions for treatment of pandemic influenza | ongoing | $0.3M | Health Canada is developing an "accelerated review process" based on the current review process models and will apply this new process for reviewing the influenza drug submissions. This accelerated review process will be posted on our regular channels of communication, including on the Web, as Guidance Document to the Industry. The reviewers are being trained on the aspects of the "accelerated review" and will be ready to apply the new protocol. | |
c. Establishment of a crisis risk management unit for monitoring and post market assessment of therapeutic products | ongoing | $0.4M | Emergency preparedness plans specific to pandemic influenza will be put into place for dealing with staff shortages and lack of trained personnel for pharmacovigilance and product vigilance. Strategies are being developed for expedited surveillance, assessment and risk communication for anti-virals and other relevant health products. Recruitment and cross training of existing staff will provide for a limited incremental increase to risk surveillance/assessment/management capacity to deal with anti-viral adverse reaction information. Communication links with F/P/T and other stakeholders will continue to be refined. |
|
d. FN/I Surge Capacity | $1.48M (2007-08 to 2009-10) | $0.4M | Ongoing development and delivery of culturally appropriate training packages for FN/I communities that will allow them to build an increased capacity to respond to avian influenza or a human pandemic with the health care workers already in those communities, helping to ensure a more rapid identification of and immediate response to any outbreaks, and thus reducing illness and death in the event of a pandemic. | |
e. Strengthening Federal Public Health capacity | ongoing | $0.7M | Enhanced capacity to deal with outbreaks/emergencies in FN/I communities, along with strengthened links to other public health and emergency preparedness actors, will allow a more timely response to avian/pandemic influenza outbreaks in these communities, thus reducing illness and death in the event of a pandemic. | |
f. First Nations & Inuit emergency preparedness, planning, training and integration | ongoing | $0.4M | Ongoing development and testing of community pandemic influenza preparedness plans in all FN/I communities, along with established emergency management communication pathways among local communities and health authorities, regional, provincial and national partners and stronger linkages with federal efforts will ensure a more effective response in the event of an outbreak in an FN/I community, and thus contribute to reduced illness and death in the event of a pandemic. | |
g. Public health on passenger conveyances | ongoing | $0.3M | A trained and prepared cadre of Emergency Health Officers and other partners at points of entry will help to ensure more timely detection, identification and remediation of avian or pandemic influenza as public health threats onboard conveyances or at ancillary service sites, thereby helping to reduce illness or death in the event of a pandemic. These measures also help improve Canada’s compliance with the International Health Regulations, although some gaps will still be present. | |
3.CIHR | a. Influenza research priorities | $21.5M (2006-07 to 2010-11) | $5.5M | Peer review and fund research projects. Develop and launch requests for research applications, if needed. Hold first annual meeting of funded researchers, stakeholders and decision makers to review progress on funded projects, research outcomes and consult on future research needs. Chair Research Sub-committee meetings of Avian and Pandemic Influenza Operations DG (APIO DG) Committee. Mid term evaluation. |
4. CFIA | a. Animal vaccine bank | $2.4M | $0.43M | Maintain a high state of preparedness for the possible use of poultry vaccination as a disease control tool during an avian influenza outbreak in order to control avian influenza in animals and prevent its spread to humans. |
b. Access to antivirals | $0.6M | $0.11M | Maintenance and exercise of protocols and strategies to provide access to antivirals to enhance the Government of Canada’s flexibility to support the initial containment of a potential avian influenza outbreak and provide appropriate protection to federal employees, ensuring a more timely and effective response to an avian influenza situation and better protection of Canadians. | |
c. Specialized equipment | $33.6M | $20.0M | Continued investment in and maintenance of specialized supplies and equipment to enhance capacity and allow a more timely and effective response to possible avian influenza outbreaks, containing the spread and contributing to better protection of Canadians. | |
d. Laboratory surge capacity and capability | $22.1M | $2.57M | Increased coordination capacity with the creation of an integrated lab network across the country (federal, provincial and university labs). This network will allow for rapid testing, detection and reporting of AI. | |
e. Field surge capacity | $5.0M | $0.87M | Ongoing development of a viable response plan for urgent needs to increase HR capacity to respond to foreign animal disease emergency response situations. | |
f. National veterinary reserve | $8.8M | $2.27M | In January 2007, the Canadian Veterinary Reserve (CVR) was established to identify available private sector veterinarians to help respond to animal health emergencies. This reserve of professional veterinarians will enhance domestic and international surge capacity, and provide expertise and rapid response capability for foreign animal disease control efforts. The CFIA will continue to promote the growth of the CVR, and provide training to CVR members. | |
g. Enhanced enforcement measures | $6.7M | $1.37M | Provide CBSA with increased veterinary expertise, in order to increase capacity to support enhanced screening procedures for live birds or poultry products at Canada’s ports of entry. These actions can mitigate the risk of future avian influenza outbreaks in Canada. | |
h. Avian and biosecurity farms | $23.9M | $4.16M | Implementation of the National Avian Biosecurity Strategy (NABS), the objective of which is horizontal integration and coordination of biosecurity-related activities, including on-farm biosecurity standards, flock management, governance, and stakeholder engagement to mitigate the introduction or spread of avian influenza and build a foundation for a sustainable industry that minimizes economic and production losses. | |
i. Real property requirements | $4.0M | $0M | Investment in real property and accommodation to support efficient work environments and locations to support the CFIA’s action plan for AI. | |
j. Domestic and wildlife surveillance program | $14.4M | $2.71M | Development of a better integrated Canadian surveillance systems, supported by a robust systems platform and the analysis and interpretation of the data collected to allow more timely identification of potential outbreaks, and more timely response to avian influenza situations. | |
k. Field training | $6.9M | $1.78M | Investment in development and delivery of an effective and appropriate training package that will contribute to a skilled and experienced workforce ready to respond to an AI outbreak. | |
l. AI enhanced management capacity | $4.0M | $0.85M | Ongoing investment in infrastructure, tools, enhanced emergency management informatics systems and staff training to increase the Agency’s capacity to track, monitor and respond to outbreaks; and help provide emergency response teams with the ability to quickly deploy the necessary equipment and resources; maintenance of mobile command centres. | |
m. Updated emergency response plans | $11.3M | $2.24M | Continued review and updating of the comprehensive emergency response plans to reflect lessons learned and the most current available scientific information. For example lessons learned from the recent 2007 HPAI outbreak in Saskatchewan and in BC’s Fraser Valley in 2004. This will strengthen capacity and achieve the desired state of readiness as rapidly as possible. This will allow CFIA to provide more effective leadership and support the provinces and territories and promote an integrated, collaborative response to possible avian influenza issues or outbreaks. Strengthened capacity for the Agency in F/P/T liaison, policy analysis and executive briefing will allow for more timely identification of issues and responsive decision making in a changing environment. | |
n. Risk assessment and modeling | $11.5M | $2.24M | Investment in an improved federal capacity for mathematical modelling, statistical analysis, and operations research on avian influenza issues will allow a better understanding of the spread of influenza and the effectiveness of disease control measures. Specifically, risk rankings for possible pathways of entry of AI to Canada will be established. These investments will allow more timely and evidence-based decision making on avian influenza responses, thus helping to reducing the risk of transmission to humans and mitigating economic and production losses. | |
o. AI research | $6.3M | $1.29M | Investment in an improved federal capacity for mathematical modelling, statistical analysis, and operations research on avian influenza issues will allow a better understanding of the spread of influenza and the effectiveness of disease control measures. These investments will allow more timely and evidence-based decision making on avian
influenza responses, thus helping to reducing the risk of transmission to humans and mitigating economic and production losses. Identification of the research gaps related to AI and development, with partners, of effective tools and knowledge to facilitate decision making and policy development. To support the need for mass depopulation and disposal, research projects are ongoing in the areas of humane euthanasia and effective disposal methodologies. |
|
p. Strengthened economic and regulatory framework | $5.4M | $1.05M | Strengthened capacity for increased regulatory review including analysis of current legislative/regulatory framework, capacity to address regulatory developments and economic options associated with Avian influenza outbreaks, and consult with stakeholders, provinces and territories. Increased regulatory review capacity will also support stronger leadership and coordination on Avian Influenza issues across government, provinces and territories, industry and internationally. | |
q. Performance and evaluation | $4.9M | $1.04M | Evaluation of activities and outcomes will allow future decision making that reflects best practices and ensures value for money, thereby ensuring that avian and pandemic influenza preparedness measures are providing Canadians with the protection they need and reinforcing public confidence in Canada’s food inspection system. | |
r. Risk communications | $9.9M | $1.58M | A risk communication and public education strategy focussed on AI prevention and preparedness, which engages stakeholders and PT governments and informs and reassures Canadians will support the federal government's leadership role, credibility, and authority. It will help to reinforce public confidence in Canada's inspection systems, before, during, and after an avian influenza situation. | |
s. International collaboration | $7.1M | $1.36M | Contribution to the global effort to slow the progression of avian influenza in support of Canada’s leadership role and international commitments designed to slow the progression of avian influenza. Continue to deploy people internationally to assist with AI preparedness and response activities e.g. International Partnership On Avian and Pandemic Influenza (IPAPI). |
|
Total $127.72M | ||||
Results to be Achieved by Non-federal Partners (if applicable) |
Contact Information: Dr. Arlene King Director GeneralPandemic Preparedness Infectious Disease & Emergency Preparedness Branch Public Health Agency of Canada 130 Colonnade Road Ottawa ON K1A 0K9 (613) 948-7929 |
Further information on the above-mentioned horizontal initiatives see http://www.tbs-sct.gc.ca/est-pre/estime.asp
The following table lists all upcoming internal audits that pertain to the Agency's work. For links to completed audits, see http://www.phac-aspc.gc.ca/about_apropos/audit/reports_e.html
Name of Internal Audit | Audit Type | Status | Expected Completion Date |
Proactive Disclosure of Position Reclassification | Continuous Auditing and Monitoring | Reporting | June 2007 |
Audit of Contracts under $10K | Continuous Auditing and Monitoring | Reporting | July 2007 |
Contracting and procurement activities | Performance Audit | Reporting | July 2007 |
Travel and Hospitality Audit | Performance Audit | Reporting | December 2007 |
Proactive disclosure of Travel and Hospitality | Continuous Auditing and Monitoring | Reporting | December 2007 |
Human Resources Management Framework | Performance Audit | In progress | March 2008 |
Proactive Disclosure of G and C’s over $25K | Continuous Auditing and Monitoring | Planned | March 2008 |
Audit of Public Health Program practices (including G’s and C’s) | Performance Audit | Planned | May 2008 |
Delegation of Financial signing authorities | Continuous Auditing and Monitoring | In progress | June 2008 |
Health Promotion Programs | Performance Audit | Planned | September 2008 |
Resource Allocation Process | Performance Audit | Planned | December 2008 |
Infectious Disease and Prevention and Control Program | Performance Audit | Planned | March 2009 |
Property Management | Performance Audit | Planned | March 2009 |
Fundamental Control Assessment | Continuous Auditing and Monitoring | Planned | June 2009 |
Financial Statement Readiness Assessment | Continuous Auditing and Monitoring | Planned | September 2009 |
Chronic Disease and Injury Prevention and Control Program | Performance Audit | Planned | December 2009 |
Regulations | Expected Results |
Public Health Information Regulations: The Regulatory Authority under section 15 of the Public Health Agency of Canada Act allows the Governor in Council, on the recommendation of the Minister, to make regulations respecting: (a) the collection, analysis, interpretation, publication and distribution of information relating to public health, for the purpose of paragraph 4(2)(h) of the Department of Health Act; and (b) the protection of that information if it is confidential information, including if it is personal information as defined in section 3 of the Privacy Act. |
These regulations are intended to enable the Agency to lawfully collect, analyze, interpret, publish and distribute public health information in a more coordinated fashion for the purposes of minimizing public health risks to Canadians. |
Quarantine Regulations: A new Quarantine Act was recently brought into force, and the outdated Regulations were repealed, with the exception of two. Other appropriate regulations may be developed under the new Quarantine Act. | Regulations that may be developed include specifications for quarantine stations and facilities; information to be provided by conveyance operators and any other traveller on board; the protection of personal information collected under the Act; and the conduct of physical examinations to be carried out for the purpose of a health assessment. |
($ millions) | 2008-09 |
Accommodation provided by Public Works and Government Services Canada | 14.7 |
Contributions covering employers’ share of employees’ insurance premiums and expenditures paid by the Treasury Board of Canada Secretariat | 13.9 |
Salary and associated expenditures of legal services provided by the Department of Justice Canada | 0.1 |
Total services received without charge | 28.7 |
($ millions) | Forecast Revenue 2007-08 |
Planned Revenue 2008-09 |
Planned Revenue 2009-10 |
Planned Revenue 2010-11 |
Emergency Preparedness and Response | ||||
Sale to federal and provincial territorial departments and agencies, airports and other federally regulated organizations of first aid kits to be used in disaster and emergency situations | 0.1 | 0.1 | 0.1 | 0.1 |
Total Respendable Revenue | 0.1 | 0.1 | 0.1 | 0.1 |